GitLab (GTLB) 10-Q5 Dec 222023 Q3 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares shares in Millions	9 Months Ended
Cover - shares shares in Millions	Oct. 31, 2022	Nov. 25, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2022
Document Transition Report	false
Entity File Number	001-40895
Entity Registrant Name	GITLAB INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-1861035
Title of 12(b) Security	Class A common stock, par value $0.0000025per share
Trading Symbol	GTLB
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Address, Address Line One	251 Little Falls Drive
Entity Address, City or Town	Wilmington
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19808
Entity Central Index Key	0001653482
Current Fiscal Year End Date	--01-31
Current Fiscal Year Focus	2023
Current Fiscal Period Focus	Q3
Amendment Flag	false
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		91.2
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		58.5

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Oct. 31, 2022	Jan. 31, 2022
CURRENT ASSETS:
Cash and cash equivalents	[1]	$ 372,169	$ 884,672
Short-term investments	[1]	555,583	50,031
Accounts receivable, net of allowance for doubtful accounts of $950 and $1,098 as of October 31, 2022 and January 31, 2022, respectively	[1]	97,580	77,233
Deferred contract acquisition costs, current	[1]	23,599	24,363
Prepaid expenses and other current assets	[1]	20,454	15,544
Total current assets	[1]	1,069,385	1,051,843
Property and equipment, net	[1]	5,560	3,271
Equity method investment	[1]	13,624	0
Goodwill	[1]	8,145	8,145
Intangible assets, net	[1]	4,484	6,285
Deferred contract acquisition costs, non-current	[1]	14,240	14,743
Other long-term assets	[1]	4,803	7,151
TOTAL ASSETS	[1]	1,120,241	1,091,438
CURRENT LIABILITIES:
Accounts payable	[1]	6,233	4,984
Accrued expenses and other current liabilities	[1]	23,753	24,571
Accrued compensation and benefits	[1]	16,716	32,820
Deferred revenue, current	[1]	217,777	179,224
Total current liabilities	[1]	264,479	241,599
Deferred revenue, non-current	[1]	28,946	32,568
Other non-current liabilities	[1]	12,125	18,002
TOTAL LIABILITIES	[1]	305,550	292,169
Commitments and contingencies (Note 14)	[1]
STOCKHOLDERS’ EQUITY:
Preferred stock, $0.0000025 par value; 50,000 shares authorized as of October 31, 2022 and January 31, 2022; no shares issued and outstanding as of October 31, 2022 and January 31, 2022	[1]	0	0
Additional paid-in capital	[1]	1,453,349	1,320,479
Accumulated deficit	[1]	(686,915)	(553,337)
Accumulated other comprehensive income/(loss)	[1]	(2,874)	7,724
Total GitLab stockholders’ equity	[1]	763,560	774,866
Noncontrolling interests	[1]	51,131	24,403
TOTAL STOCKHOLDERS’ EQUITY	[1]	814,691	799,269
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	[1]	1,120,241	1,091,438
Class A Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, value, issued	[1]	0	0
Class B Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, value, issued	[1]	$ 0	$ 0

[1](1) As of October 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $59.5 million and $17.7 million, respectively, and liabilities of $4.5 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands		Oct. 31, 2022	Jan. 31, 2022
Allowance for doubtful accounts		$ 950	$ 1,098
STOCKHOLDERS’ EQUITY:
Preferred stock, par value (in USD per share)		$ 0.0000025	$ 0.0000025
Preferred stock, shares authorized (in shares)		50,000,000	50,000,000
Preferred stock, shares issued (in shares)		0	0
Preferred stock, shares outstanding (in shares)		0	0
Assets of consolidated variable interest entity	[1]	$ 1,120,241	$ 1,091,438
Liabilities	[1]	305,550	292,169
Variable Interest Entity, Primary Beneficiary
STOCKHOLDERS’ EQUITY:
Assets of consolidated variable interest entity		59,502	17,732
Liabilities		$ 4,527	$ 3,663
Class A Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, par value (in USD per share)		$ 0.0000025	$ 0.0000025
Common stock, shares authorized (in shares)		1,500,000,000	1,500,000,000
Common stock, shares issued (in shares)		91,151,000	27,141,000
Common stock, shares outstanding (in shares)		91,151,000	27,141,000
Class B Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, par value (in USD per share)		$ 0.0000025	$ 0.0000025
Common stock, shares authorized (in shares)		250,000,000	250,000,000
Common stock, shares issued (in shares)		58,503,000	119,747,000
Common stock, shares outstanding (in shares)		58,503,000	119,747,000

[1](1) As of October 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $59.5 million and $17.7 million, respectively, and liabilities of $4.5 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Revenue	$ 112,981	$ 66,800	$ 301,429	$ 174,857
Cost of revenue	14,564	7,195	37,442	20,812
Gross profit	98,417	59,605	263,987	154,045
Operating expenses:
Sales and marketing	81,080	50,543	228,479	133,562
Research and development	41,113	24,664	112,463	68,607
General and administrative	33,186	16,939	88,182	40,276
Total operating expenses	155,379	92,146	429,124	242,445
Loss from operations	(56,962)	(32,541)	(165,137)	(88,400)
Interest income	4,657	127	8,247	226
Other income (expense), net	2,661	(10,209)	22,609	(21,252)
Loss before income taxes and loss from equity method investment	(49,644)	(42,623)	(134,281)	(109,426)
Loss from equity method investment, net of tax	(756)	0	(1,775)	0
Provision for (benefit from) income taxes	65	(875)	2,519	1,370
Net loss	(50,465)	(41,748)	(138,575)	(110,796)
Net loss attributable to noncontrolling interest	(2,010)	(521)	(4,997)	(1,443)
Net loss attributable to GitLab	$ (48,455)	$ (41,227)	$ (133,578)	$ (109,353)
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted
Basic (in USD per share)	$ (0.33)	$ (0.62)	$ (0.90)	$ (1.89)
Diluted (in USD per share)	$ (0.33)	$ (0.62)	$ (0.90)	$ (1.89)
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted
Basic (in shares)	148,883,000	67,018,000	147,812,000	57,789,000
Diluted (in shares)	148,883,000	67,018,000	147,812,000	57,789,000
Subscription—self-managed and SaaS
Revenue	$ 98,435	$ 59,774	$ 264,294	$ 156,542
Cost of revenue	11,113	5,608	29,717	16,366
License—self-managed and other
Revenue	14,546	7,026	37,135	18,315
Cost of revenue	$ 3,451	$ 1,587	$ 7,725	$ 4,446

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (50,465)	$ (41,748)	$ (138,575)	$ (110,796)
Foreign currency translation adjustments	(5,740)	9,768	(9,532)	19,157
Net change in unrealized gains or losses on available-for-sale securities	(4,521)	0	(7,044)	0
Comprehensive loss including noncontrolling interest	(60,726)	(31,980)	(155,151)	(91,639)
Net loss attributable to noncontrolling interest	(2,010)	(521)	(4,997)	(1,443)
Foreign currency translation adjustments attributable to noncontrolling interest	(3,931)	0	(5,978)	0
Comprehensive loss attributable to noncontrolling interest	(5,941)	(521)	(10,975)	(1,443)
Comprehensive loss attributable to GitLab	$ (54,785)	$ (31,459)	$ (144,176)	$ (90,196)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total		Common Stock Class A Common Stock	Common Stock Class B Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive (Loss) Income	Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ (231,222)		$ 0	$ 0	$ 186,892	$ (398,199)	$ (19,915)	$ 0
Convertible Preferred Stock, beginning balance (in shares) at Jan. 31, 2021	79,551,000
Convertible Preferred Stock, beginning balance at Jan. 31, 2021	$ 424,904
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of convertible preferred stock to Class B common stock upon initial public offering (in shares)	(79,551,000)
Conversion of convertible preferred stock to Class B common stock upon initial public offering	$ (424,904)
Convertible Preferred Stock, ending balance (in shares) at Oct. 31, 2021	0
Convertible Preferred Stock, ending balance at Oct. 31, 2021	$ 0
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2021			1,151,000	52,468,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of stock (in shares)				79,551,000
Conversion of stock	424,904				424,904
Conversion of Class B common stock to Class A common stock by the selling stockholder (CEO) upon initial public offering (in shares)			2,500,000	(2,500,000)
Issuance of common stock upon initial public offering, net of underwriting discounts and other offering costs (in shares)			8,940,000
Issuance of common stock upon initial public offering, net of underwriting discounts and other offering costs	649,845				649,845
Repurchase of common stock (in shares)				(13,000)
Repurchase of common stock	(590)				(590)
Issuance of common stock related to vested exercised stock options (in shares)				1,881,000
Issuance of common stock related to vested exercised stock options	8,992				8,992
Issuance of common stock related to early exercised stock options, net of repurchases (in shares)				568,000
Vesting of early exercised stock options	5,425				5,425
Stock-based compensation expense	17,242				17,242
Other comprehensive (loss) income	19,157						19,157
Change in noncontrolling interest ownership due to capital contributions from noncontrolling interest holders, net of issuance costs	26,450							26,450
Net loss	(110,796)					(109,353)		(1,443)
Stockholders' Equity, ending balance (in shares) at Oct. 31, 2021			12,591,000	131,955,000
Stockholders' Equity, ending balance at Oct. 31, 2021	809,407		$ 0	$ 0	1,292,710	(507,552)	(758)	25,007
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ (250,485)		$ 0	$ 0	200,838	(466,325)	(10,526)	25,528
Convertible Preferred Stock, beginning balance (in shares) at Jul. 31, 2021	79,551,000
Convertible Preferred Stock, beginning balance at Jul. 31, 2021	$ 424,904
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of convertible preferred stock to Class B common stock upon initial public offering (in shares)	(79,551,000)
Conversion of convertible preferred stock to Class B common stock upon initial public offering	$ (424,904)
Convertible Preferred Stock, ending balance (in shares) at Oct. 31, 2021	0
Convertible Preferred Stock, ending balance at Oct. 31, 2021	$ 0
Stockholders' Equity, beginning balance (in shares) at Jul. 31, 2021			1,151,000	53,893,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of stock (in shares)				79,551,000
Conversion of stock	424,904				424,904
Conversion of Class B common stock to Class A common stock by the selling stockholder (CEO) upon initial public offering (in shares)			2,500,000	(2,500,000)
Issuance of common stock upon initial public offering, net of underwriting discounts and other offering costs (in shares)			8,940,000
Issuance of common stock upon initial public offering, net of underwriting discounts and other offering costs	649,845				649,845
Issuance of common stock related to vested exercised stock options (in shares)				856,000
Issuance of common stock related to vested exercised stock options	4,572				4,572
Issuance of common stock related to early exercised stock options, net of repurchases (in shares)				155,000
Vesting of early exercised stock options	3,972				3,972
Stock-based compensation expense	8,579				8,579
Other comprehensive (loss) income	9,768						9,768
Net loss	(41,748)					(41,227)		(521)
Stockholders' Equity, ending balance (in shares) at Oct. 31, 2021			12,591,000	131,955,000
Stockholders' Equity, ending balance at Oct. 31, 2021	809,407		$ 0	$ 0	1,292,710	(507,552)	(758)	25,007
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	809,407		0	0	1,292,710	(507,552)	(758)	25,007
Stockholders' Equity, beginning balance	$ 799,269	[1]	$ 0	$ 0	1,320,479	(553,337)	7,724	24,403
Convertible Preferred Stock, beginning balance (in shares) at Jan. 31, 2022	0
Convertible Preferred Stock, beginning balance at Jan. 31, 2022	$ 0
Convertible Preferred Stock, ending balance (in shares) at Oct. 31, 2022	0
Convertible Preferred Stock, ending balance at Oct. 31, 2022	$ 0
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2022			27,141,000	119,747,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of stock (in shares)			63,178,000	(63,178,000)
Issuance of common stock related to vested exercised stock options (in shares)	1,993,000			1,970,000
Issuance of common stock related to vested exercised stock options	$ 17,603				17,603
Issuance of common stock under employee stock purchase plan (in shares)			289,000
Issuance of common stock under employee stock purchase plan	9,554				9,554
Issuance of common stock related to early exercised stock options, net of repurchases (in shares)				(36,000)
Issuance of common stock related to RSUs vested, net of tax withholdings (in shares)			543,000
Vesting of early exercised stock options	4,106				4,106
Stock-based compensation expense	88,926				83,454			5,472
Other comprehensive (loss) income	(16,576)						(10,598)	(5,978)
Change in noncontrolling interest ownership due to capital contributions from noncontrolling interest holders, net of issuance costs	61,726				18,153			43,573
Deconsolidation of Meltano Inc.	(11,342)							(11,342)
Net loss	(138,575)					(133,578)		(4,997)
Stockholders' Equity, ending balance (in shares) at Oct. 31, 2022			91,151,000	58,503,000
Stockholders' Equity, ending balance at Oct. 31, 2022	814,691	[1]	$ 0	$ 0	1,453,349	(686,915)	(2,874)	51,131
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ 830,320		$ 0	$ 0	1,413,491	(638,460)	3,456	51,833
Convertible Preferred Stock, beginning balance (in shares) at Jul. 31, 2022	0
Convertible Preferred Stock, beginning balance at Jul. 31, 2022	$ 0
Convertible Preferred Stock, ending balance (in shares) at Oct. 31, 2022	0
Convertible Preferred Stock, ending balance at Oct. 31, 2022	$ 0
Stockholders' Equity, beginning balance (in shares) at Jul. 31, 2022			83,025,000	65,746,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of stock (in shares)			7,810,000	(7,810,000)
Issuance of common stock related to vested exercised stock options (in shares)				584,000
Issuance of common stock related to vested exercised stock options	6,190				6,190
Issuance of common stock related to early exercised stock options, net of repurchases (in shares)				(17,000)
Issuance of common stock related to RSUs vested, net of tax withholdings (in shares)			316,000
Vesting of early exercised stock options	1,146				1,146
Stock-based compensation expense	33,708				31,208			2,500
Other comprehensive (loss) income	(10,261)						(6,330)	(3,931)
Change in noncontrolling interest ownership due to capital contributions from noncontrolling interest holders, net of issuance costs	4,053				1,314			2,739
Net loss	(50,465)					(48,455)		(2,010)
Stockholders' Equity, ending balance (in shares) at Oct. 31, 2022			91,151,000	58,503,000
Stockholders' Equity, ending balance at Oct. 31, 2022	814,691	[1]	$ 0	$ 0	1,453,349	(686,915)	(2,874)	51,131
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ 814,691	[1]	$ 0	$ 0	$ 1,453,349	$ (686,915)	$ (2,874)	$ 51,131

[1](1) As of October 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $59.5 million and $17.7 million, respectively, and liabilities of $4.5 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2022		Oct. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss, including amounts attributable to noncontrolling interest	$ (138,575)		$ (110,796)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	88,926		17,242
Amortization of intangible assets	1,767		251
Depreciation expense	2,198		0
Amortization of deferred contract acquisition costs	32,693		23,555
Gain from deconsolidation of Meltano Inc.	(17,798)		0
Loss from equity method investment	2,247		0
Net amortization of premiums or discounts on short-term investments	(3,346)		0
Unrealized foreign exchange (gain) loss	(4,081)		19,752
Other non-cash (income) expense	439		(128)
Changes in assets and liabilities:
Accounts receivable	(22,163)		(17,350)
Prepaid expenses and other current assets	(5,320)		(3,373)
Deferred contract acquisition costs	(33,145)		(24,642)
Other long-term assets	2,050		(3,120)
Accounts payable	1,393		1,786
Accrued expenses and other current liabilities	3,249		1,019
Accrued compensation and benefits	(15,150)		3,812
Deferred revenue	40,200		41,469
Other long-term liabilities	(1,272)		1,803
Net cash used in operating activities	(65,688)		(48,720)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of short-term investments	(631,951)		(100,031)
Proceeds from maturities of short-term investments	122,701		0
Purchases of property and equipment	(5,018)		0
Deconsolidation of Meltano Inc.	(9,620)		0
Net cash used in investing activities	(523,888)		(100,031)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from initial public offering, net of underwriting discounts	0		654,552
Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases	17,454		14,574
Issuance of common stock under employee stock purchase plan	9,554		0
Repurchase of common stock in a tender offer	0		(590)
Contributions received from noncontrolling interests, net of issuance costs	61,726		26,450
Partial settlement of acquisition related contingent cash consideration	(3,137)		0
Payments of deferred offering costs	0		(3,398)
Net cash provided by financing activities	85,597		691,588
Impact of foreign exchange on cash and cash equivalents	(8,524)		(973)
Net increase (decrease) in cash and cash equivalents	(512,503)		541,864
Cash, cash equivalents, and restricted cash at beginning of period	887,172		282,850
Cash, cash equivalents, and restricted cash at end of period	374,669		824,714
Supplemental disclosure of cash flow information:
Cash paid for income taxes	527		1,111
Cash donations	0		1,000
Vesting of early exercised stock options	4,106		5,425
Issuance of common stock upon conversion of preferred stock	0		424,904
Unpaid deferred offering costs	0		1,309
Reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above:
Cash and cash equivalents	372,169	[1]	824,714
Restricted cash, current included in prepaid expenses and other current assets	2,500		0
Total cash, cash equivalents and restricted cash	$ 374,669		$ 824,714

[1](1) As of October 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $59.5 million and $17.7 million, respectively, and liabilities of $4.5 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Organization and Description of

Organization and Description of Business	9 Months Ended
Organization and Description of Business	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	1. Organization and Description of Business GitLab Inc. (the “Company”) began as an open source project in 2011 and was incorporated in Delaware on September 12, 2014. While the Company is headquartered in San Francisco, California, it operates on an all-remote model. The Company is a technology company and its primary offering is “GitLab”, a complete DevSecOps platform delivered as a single application. GitLab is used by a wide range of organizations. The Company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service ("SaaS") models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The Company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world to help them become better software-led businesses.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	2. Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. Fiscal Year The Company's fiscal year ends on January 31. For example, references to fiscal 2023 and 2022 refer to the fiscal year ending January 31, 2023 and the fiscal year ended January 31, 2022, respectively. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates include, but are not limited to, allocation of revenue to the license element in the Company's self-managed subscriptions, estimating the amortization period for capitalized costs to obtain a contract, allowance for doubtful accounts, stock-based compensa tion expense, fair value of contingent consideration, fair valuation of retained interest in an investee on loss of control, valuation allowance for deferred income taxes and valuation of intangibles assets . The Company bases these estimates on historical and anticipated results, tre nds, and various other assumptions, including the impact of the COVID-19 pandemic, that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates. The novel coronavirus, or COVID-19, pandemic has created, and may continue to create, significant uncertainty in macroeconomic conditions. The global impact of COVID-19 continues to rapidly evolve, and the Company will continue to monitor the situation and the effects on its business and operations closely. The Company does not yet know the full extent of potential impacts on its business or operations or on the global economy as a whole, particularly if the COVID-19 pandemic continues and persists for an extended period of time. Principles of Consolidation The condensed consolidated financial statements include 100% of the accounts of wholly owned subsidiaries and a variable interest entity for which our Company is the primary beneficiary. The ownership interest of other investors is recorded as noncontrolling interest. All intercompany accounts and transactions have been eliminated in consolidation. Summary of Significant Accounting Policies There were no significant changes to the Company’s significant accounting policies disclosed in “Note 2” of the Company’s Annual Report on Form 10-K f or the fiscal year ended January 31, 2022, except for the addition of policies in respect of short-term investments - marketable securities, equity method investment in Meltano Inc., the Company’s former wholly-owned subsidiary, and an update to the stock-based compensation policy to cover the Company’s recently granted performance stock units (“PSUs”). Short-Term Investments - Marketable Securities The Company classifies its marketable securities with stated maturities of three months and greater as short-term investments due to its ability to use these securities to support the Company’s current operations. As of October 31, 2022, all short-term investments are classified as available-for-sale and are reported at fair value, which is based on quoted market prices for such securities, if available, or based on quoted market prices of financial instruments with similar characteristics. Unrealized gains and losses are recorded as a separate component of other comprehensive loss, net of tax. Realized gains and losses on available-for-sale securities are recognized upon sale and are included in other income (expense), net in the condensed consolidated statements of operations. The Company periodically reviews its available-for-sale securities to determine if there has been an other-than-temporary decline in fair value. Factors considered in determining whether a loss is other-than-temporary include, but are not limited to: the length of time and extent a security’s fair value has been below its cost, the financial condition and near-term prospects of the investee, the credit quality of the security’s issuer, likelihood of recovery and the Company’s intent and ability to hold the security for a period of time sufficient to allow for any anticipated recovery in value. No changes in fair value due to impairment have been recorded in earnings for available-for-sale securities during the periods presented. Equity Method Investment The Company applies the equity method of accounting to investments when it has significant influence, but not controlling interest in the investee. The Company’s equity method investments are reported at cost and adjusted each period for its proportionate share of the investee’s income or loss. The cost on initial recognition of retained interest in an erstwhile subsidiary is based on fair value on the date of loss of control. The Company’s proportionate share of the net loss resulting from the investment is reported under loss from equity method investment, net of tax in our condensed consolidated statements of operations. The carrying value of the Company’s equity method investments is reported in equity method investment in the condensed consolidated balance sheets. The Company assesses investments for impairment whenever events or changes in circumstances indicate that the carrying value of an investment may not be recoverable. Stock-Based Compensation Our PSUs issued to the senior members of the management team are subject to a revenue performance condition and service conditions. The number of PSUs that will ultimately vest will depend on the revenue achieved by the Company in fiscal 2025 relative to the defined target. The fair value of PSUs is measured at the market price of the Company’s Class A common stock on the date of grant and compensation costs related to these awards are recognized on a graded-vesting method over the requisite service period. Recently Adopted Accounting Standards In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which simplifies the accounting for income taxes by eliminating some exceptions to the general approach in ASC 740, Income Taxes in order to reduce cost and complexity of its application. The Company adopted ASU 2019-12 as of February 1, 2022 with no material impact. Recently Issued Accounting Standards Not Yet Adopted In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820) (“Topic 820”): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (“ASU 2022-03”). ASU 2022-03 clarifies the guidance in Topic 820 that a contractual restriction on the sale of an equity security should not be considered in measuring fair value, and introduces new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. For public companies, the amendments to ASU 2022-03 are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2024, and interim periods within those fiscal years. The adoption of ASU 2022-03 is not expected to have a material effect on the Company’s condensed consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) (“Topic 842”). Topic 842 supersedes the lease requirements in ASC Topic 840, Leases . Under Topic 842, lessees are required to recognize assets and liabilities on the condensed consolidated balance sheet for most leases and provide enhanced disclosures. Leases will continue to be classified as either finance or operating. For public companies, Topic 842 is effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. The Company has elected to use the extended transition period that allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies under the JOBS Act. For as long as the Company remains an “emerging growth company,” the new guidance is effective for annual reporting periods beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The adoption of ASU 2016-02 is not expected to have a material effect on the Company’s condensed consolidated financial statements. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost. ASU 2016-13 replaces the existing incurred loss impairment model with an expected loss methodology, which will result in more timely recognition of credit losses. Since the Company follows private company’s adoption timelines, this new guidance is effective for the Company for its fiscal year beginning February 1, 2023. The Company is currently evaluating the effect of the adoption of ASU 2016-13 on its condensed consolidated financial statements. The effect will largely depend on the composition and credit quality of the Company's portfolio of financial assets and the economic conditions at the time of adoption.

Revenues

Revenues	9 Months Ended
Revenues	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenues	3. Revenues Disaggregation of Revenue The following table shows the components of revenues and their respective percentages of total revenue for the periods indicated (in thousands, except percentages): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Subscription—self-managed and SaaS $ 98,435 87 % $ 59,774 89 % $ 264,294 88 % $ 156,542 90 % Subscription—self-managed 72,720 64 47,215 70 199,335 66 124,742 72 SaaS 25,715 23 12,559 19 64,959 22 31,800 18 License—self-managed and other $ 14,546 13 % $ 7,026 11 % $ 37,135 12 % $ 18,315 10 % License—self-managed 11,860 11 5,314 8 30,646 10 13,757 8 Professional services and other 2,686 2 1,712 3 6,489 2 4,558 2 Total revenue $ 112,981 100 % $ 66,800 100 % $ 301,429 100 % $ 174,857 100 % Total Revenue by Geographic Location The following table summarizes the Company’s total revenue by geographic location based on the region of the Company’s contracting entity, which may be different than the region of the customer (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 United States $ 94,942 $ 56,706 $ 251,339 $ 147,226 Europe 15,547 9,165 43,285 24,631 Asia Pacific 2,492 929 6,805 3,000 Total revenue $ 112,981 $ 66,800 $ 301,429 $ 174,857 During the three and nine months ended October 31, 2022, the United States accounted for 84% and 83% of total revenue, respectively. During the three and nine months ended October 31, 2021, the United States accounted for 85% and 84% of total revenue, respectively. No other individual country exceeded 10% of total revenue for any of the periods presented. The Company operates its business as a single reportable segment. Deferred Revenue During the three and nine months ended October 31, 2022, $77.0 million and $141.9 million of revenue was recognized from deferred revenue as of the beginning of the period, respectively. During the three and nine months ended October 31, 2021, $45.0 million and $78.4 million of revenue was recognized from deferred revenue as of the beginning of the period, respectively. Remaining Performance Obligations As of October 31, 2022 and January 31, 2022, the aggregate amount of the transaction price allocated to billed and unbilled remaining performance obligations for which revenue has not yet been recognized was approximately $392.7 million and $312.4 million, respectively. As of October 31, 2022, the Company expects to recognize approximately 71% of the transaction price as product or services revenue over the next 12 months and 92% over the next 24 months. Concentration of Credit Risk and Significant Customers Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, short-term investments, and accounts receivable. At times, cash deposits may be in excess of insured limits. The Company believes that the financial institutions or corporations that hold its cash, cash equivalents, restricted cash, and short-term investments are financially sound and, accordingly, minimal credit risk exists with respect to these balances. The Company maintains allowances for potential credit losses on accounts receivable when deemed necessary. The Company uses various distribution channels. A s of October 31, 2022, t h ere were three distribution channel entities who individually represented 16%, 11% and 10% of t he accounts receivabl e balance. There was one distribution channel entity whose balance represented 14% of the accounts receivable balance as of January 31, 2022.

Cash, Cash Equivalents and Shor

Cash, Cash Equivalents and Short-Term Investments	9 Months Ended
Cash, Cash Equivalents and Short-Term Investments	Oct. 31, 2022
Cash and Cash Equivalents [Abstract]
Cash, Cash Equivalents and Short-Term Investments	4. Cash, Cash Equivalents and Short-Term Investments The following table summarizes the Company’s cash, cash equivalents and short-term investments by category (in thousands): As of October 31, 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Cash and cash equivalents: Cash $ 279,997 $ — $ — $ 279,997 Money market funds 71,218 — — 71,218 U.S. Treasury securities 14,978 — (1) 14,977 U.S. Agency securities 5,981 — (4) 5,977 Total cash and cash equivalents $ 372,174 $ — $ (5) $ 372,169 Short-term investments: Commercial paper 39,112 — (226) 38,886 Corporate debt securities 49,338 — (852) 48,486 Municipal bonds 1,981 — (30) 1,951 Foreign government bonds 2,198 — (42) 2,156 U.S. Agency securities 36,256 — (492) 35,764 U.S. Treasury securities 433,737 — (5,397) 428,340 Total short-term investments $ 562,622 $ — $ (7,039) $ 555,583 As of January 31, 2022, the Company had $884.7 million of cash and cash equivalents, and $50.0 million of short-term investments, comprised of certificates of deposit with a bank with an original maturity of greater than three months at the date of purchase. Such investments were carried at amortized cost, which approximated their fair value and matured during the nine months ended October 31, 2022. The Company uses the specific-identification method to determine an y realized gains or losses from the sale of our short-term investments classified as available-for-sale. During the three and nine months ended October 31, 2022, the Company did not have any material realized gains or losses as a result of maturities or sales of short-term investments. During the three and nine months ended October 31, 2022, the Company recorded $4.7 million and $8.2 million of interest income on cash equivalents and short-term investments, respectively, which includes $2.1 million and $3.3 million of net amortization of premiums or discounts on short-term investments during the three and nine months ended October 31, 2022, respectively. During the three and nine months ended October 31, 2021, the Company recorded $0.1 million and $0.2 million of interest income on cash equivalents and short-term investments, respectively. The Company did not record any amortization of premiums or discounts during the three and nine months ended October 31, 2021. As of October 31, 2022 , the Company does not have an y cash equivalents and short-term investments that have been in a continuous unrealized gain or loss position for more than 12 months as of the periods presented. The following table summarizes unrealized losses on our cash equivalents and sh ort-term investments by category that have been in a continuous unrealized loss position for less than 12 months as of the periods presented (in thousands): Carrying Value Gross Unrealized Losses October 31, 2022 U.S. Agency securities $ 41,741 $ (496) Commercial paper 33,886 (226) Corporate debt securities 48,486 (852) Municipal bonds 1,951 (30) Foreign government bonds 2,156 (42) U.S. Treasury securities 438,318 (5,398) Total cash equivalents and short-term investments $ 566,538 $ (7,044) The following table classifies the Company’s short-term investments by contractual maturities (in thousands): October 31, 2022 January 31, 2022 Amortized cost Fair Value Amortized cost Fair Value Due within 1 year $ 433,053 $ 428,649 $ 50,031 $ 50,031 Due between 1 year to 2 years 129,569 126,934 — — Total $ 562,622 $ 555,583 $ 50,031 $ 50,031 All available-for-sale securities have been classified as current, based on management’s ability to use the funds in current operations.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	5. Fair Value Measurements The Company determines fair value based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value assumes that the transaction to sell the asset or transfer the liability occurs in the principal or most advantageous market for the asset or liability and establishes that the fair value of an asset or liability shall be determined based on the assumptions that market participants would use in pricing the asset or liability. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the fair value measurement. The fair value hierarchy prioritizes the inputs into three levels that may be used to measure fair value: Level 1: Inputs are unadjusted quoted prices in active markets for identical assets or liabilities. Level 2: Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3: Inputs are unobservable based on the Company’s own assumptions used to measure assets and liabilities at fair value. The inputs require significant management judgment or estimation. The fair value of the Company’s Level 1 financial instruments, such as money market funds which are traded in active markets, is based on quoted market prices for identical instruments. The fair value of the Company’s Level 2 financial instrumen ts such as commercial paper, corporate debt and U.S. government securities are obtained from an independent pricing service, which may use inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security that may not be actively traded. The Company’s marketable securities are held by custodians who obtain investment prices from a third-party pricing provider that incorporates standard inputs in various asset price models. Financial assets measured at fair value on a recurring basis are summarized below (in thousands): Level 1 Level 2 Level 3 Fair Value October 31, 2022 (1) Cash equivalents: Money market funds $ 71,218 $ — $ — $ 71,218 U.S. Agency securities — 5,977 — 5,977 U.S. Treasury securities — 14,977 — 14,977 Short-term investments: Commercial paper — 38,886 — 38,886 Corporate debt securities — 48,486 — 48,486 Municipal bonds — 1,951 — 1,951 Foreign government bonds — 2,156 — 2,156 U.S. Agency securities — 35,764 — 35,764 U.S. Treasury securities — 428,340 — 428,340 Total $ 71,218 $ 576,537 $ — $ 647,755 (1) Exclu des $280.0 million in cash held in the Company’s bank accounts as of October 31, 2022.

Supplemental Financial Statemen

Supplemental Financial Statement Information	9 Months Ended
Supplemental Financial Statement Information	Oct. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Supplemental Financial Statement Information	6. Supplemental Financial Statement Information Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands): October 31, 2022 January 31, 2022 Prepaid software subscriptions $ 7,028 $ 3,950 Prepaid advertising costs 737 722 Security and other deposits 1,005 981 Prepaid insurance 76 4,309 Prepaid income taxes 3,893 3,168 Restricted cash (1) 2,500 — Interest receivable 1,485 49 Prepaid expenses for the Company’s events 1,093 266 Other prepaid expenses 1,818 1,834 Other current assets 819 265 Total prepaid expense and other current assets $ 20,454 $ 15,544 (1) Refer to “Note 7. Business Combination”. Property and Equipment, Net Property and equipment, net of the following (in thousands): October 31, 2022 January 31, 2022 Computer and office equipment $ 7,315 $ 3,049 Leasehold improvements 709 765 Others 259 — 8,283 3,814 Less: Accumulated depreciation (1) (2,723) (543) Total property and equipment, net (1) $ 5,560 $ 3,271 (1) The amounts in the table above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying property and equipment. Depreciation expense of property and equipment was $0.9 million and $2.2 million for the three and nine months ended October 31, 2022, respectively, and zero for the respective periods last year. Other Long-Term Assets Other assets consisted of the following (in thousands): October 31, 2022 January 31, 2022 Security and other deposits $ 2,956 $ 2,832 Restricted cash (1) — 2,500 Deferred software implementation costs 1,088 969 Other long-term assets 759 850 Total other long-term assets $ 4,803 $ 7,151 (1) Refer to “Note 7. Business Combination”. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): October 31, 2022 January 31, 2022 Accrued expenses $ 10,956 $ 8,605 Income taxes payable 1,646 319 ESPP employee contributions 4,406 6,557 Indirect taxes payable 1,725 4,044 Acquisition related contingent cash consideration (1) — 3,029 Acquisition related consideration withheld in escrow (1) 2,500 — Customer refunds 2,467 2,017 Other current liabilities 53 — Total accrued expenses and other current liabilities $ 23,753 $ 24,571 (1) Refer to “Note 7. Business Combination”. Accrued Com pensation and Benefits Accrued compensation and benefits consisted of the following (in thousands): October 31, 2022 January 31, 2022 Accrued commissions $ 6,841 $ 8,417 Payroll taxes payable 2,073 14,506 Other accrued team member related payables 7,802 9,897 Total accrued compensation and benefits $ 16,716 $ 32,820 Other Long-Term Liabilities Other long-term liabilities consisted of the following (in thousands): October 31, 2022 January 31, 2022 Early exercised options liability $ 2,581 $ 6,837 Acquisition related contingent cash consideration (1) 5,105 4,929 Acquisition related consideration withheld in escrow (1) — 2,500 Deferred tax liabilities 1,028 379 Contingent liability for labor matters 2,493 2,573 Long term taxes payable 737 784 Other long-term liabilities 181 — Total other long-term liabilities $ 12,125 $ 18,002 (1) Refer to “Note 7. Business Combination”. Other Inc ome (Expense), Ne t Other income (expense), net consisted of the following (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Gain from deconsolidation of Meltano Inc. (1) $ — $ — $ 17,798 $ — Foreign exchange gains (losses), net 2,855 (9,831) 5,361 (19,703) Other expense, net (194) (378) (550) (1,549) Total other income (expense), net $ 2,661 $ (10,209) $ 22,609 $ (21,252) (1) Refer to “Note 11. Joint Venture and Equity Method Investment”.

Business Combination

Business Combination	9 Months Ended
Business Combination	Oct. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Business Combination	7. Business Combination On December 3, 2021, th e Company completed the acquisition of Opstrace, Inc., a technology company based in San Francisco, California. The transaction was accounted for as a business combination. The acquisition date fair value of the consideration transferred consisted of the following (in thousands): Cash consideration $ 2,970 Fair value of common stock issued on closing 959 Contingent common stock consideration (classified under additional paid-in capital) 1,754 Contingent cash consideration (paid as of October 31, 2022) 3,007 Contingent cash consideration (classified under other long-term liabilities as of October 31, 2022) 4,893 Total consideration $ 13,583 Cash consideration includes $2.5 million held back as partial security for post-closing indemnification claims made within 18 months of the closing da te recorded in a ccrued expenses and other current liabilities on the condensed consolidated balance sheet as of October 31, 2022 and in other long-term liabilities as of January 31, 2022. As a result of acquisition, the fair value of the consideration transferred included contingent cash considerations of $7.9 million in aggregate. These contingent cash considerations are determined based upon the satisfaction of certain defined operational milestones and are remeasured at fair value at each reporting period through earnings. As the fair value is based on unobservable inputs, the liabilities are included in Level 3 of the fair value measurement hierarchy. In September 2022, one of the operational milestones was achieved and the Company paid $4.2 million of contingent cash consideration, part of which was previously recorded in accrued expenses and other current liabilities. The difference of $1.1 million between the amount accrued and the amount paid was attributable to the change in fair value of the original measurement and was recorded in general and administrative expenses during the three and nine months ended October 31, 2022. Accretion expense was $0.1 million and $0.3 million for the three and nine months ended October 31, 2022, respectively. There was no accretion expense for the three and nine months ended October 31, 2021. Results of operations of the business acquired have been included in our condensed consolidated financial statements subsequent to the date of acquisition. The revenue and net income (loss) earned by the business acquired following the acquisition are not material to our condensed consolidated results of operations. Pro forma statements have not been presented because they are not material to our condensed consolidated results of operations.

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Net	9 Months Ended
Goodwill and Intangible Assets, Net	Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets, Net	8. Goodwill and Intangible Assets, Net Goodwill The carrying amount of goodwill was as follows (in thousands): Carrying Amount Balance as of October 31, 2022 and January 31, 2022 $ 8,145 There was no goodwill impairment for any periods presented. Intangible Assets Intangible assets, net consisted of the following (in thousands): October 31, 2022 Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination $ 6,200 $ (1,880) $ 4,320 2.1 Developed technology from asset acquisitions (1) 1,249 (1,085) 164 0.5 Total $ 7,449 $ (2,965) $ 4,484 January 31, 2022 Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination $ 6,200 $ (334) $ 5,866 2.8 Developed technology from asset acquisitions (1) 1,402 (983) 419 1.3 Total $ 7,602 $ (1,317) $ 6,285 (1) The amounts in the tables above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying intangibles. Amortization expense was $0.6 million and $1.8 million for the three and nine months ended October 31, 2022, respectively, and $0.1 million and $0.3 million for three and nine months ended October 31, 2021, respectively. As of October 31, 2022 , future amortization expense related to the intangibles assets is expected to be as follows (in thousands): Fiscal Years 2023 $ 591 2024 2,166 2025 1,727 Total future amortization $ 4,484

Team Member Benefit Plans

Team Member Benefit Plans	9 Months Ended
Team Member Benefit Plans	Oct. 31, 2022
Retirement Benefits [Abstract]
Team Member Benefit Plans	9. Team Member Benefit Plans The Company contributes to defined c ontribution plans in a number of countries including a 401(k) savings plan for U.S.-based team members and defined contribution arrangements in the United Kingdom, Australia, New Zealand and select other countries based on the legislative and tax requirements of the respective countries. Total contributions to these plans were $0.7 million and $2.8 million for the three and nine months ended October 31, 2022, respectively, and $0.5 million and $2.0 million for the three and nine months ended October 31, 2021, respectively.

Equity

Equity	9 Months Ended
Equity	Oct. 31, 2022
Equity [Abstract]
Equity	10. Equity In connection with the IPO, on October 18, 2021, the Company filed a restated certificate of incorporation that authorized the issuance of 1,500,000,000 shares of Class A common stock, 250,000,000 shares of Class B common stock, and 50,000,000 shares of preferred stock at $0.0000025 par value for each class of shares. Common stockholders are entitled to dividends when and if declared by the board of directors. No dividends have been declared to date. The holder of each share of Class A common stock is entitled to one vote and the holder of each share of Class B common stock is entitled to ten votes. Common Stock The Company had shares of common stock reserved for future issuance as follows (in thousands): October 31, 2022 January 31, 2022 Class A and Class B common stock Options issued and outstanding 13,873 17,146 Shares available for issuance under Equity Incentive Plans 22,068 18,248 RSUs and PSUs issued and outstanding 7,909 3,280 Shares reserved for issuance to charitable organizations 1,636 1,636 2021 ESPP 4,451 3,271 Total 49,937 43,581 Early Exercised Options (subject to a repurchase right) Certain stock option holders have the right to exercise unvested options, subject to a repurchase right held by the Company at the original exercise price, in the event of voluntary or involuntary termination of employment of the holder. As of October 31, 2022 and January 31, 2022 , there were 267,804 and 713,967 shares, respectively, of unvested options that had been early exercised and were subject to repurchase for a total liability of $2.6 million and $6.8 million, respective ly. The liability associated with early exercised options is included in other long-term liabilities in the condensed consolidated balance sheets. For accounting purposes, issuance of shares will be recognized only on vesting. However, shares issued for the early exercise of options are included in issued and outstanding shares as they are legally issued and outstanding. Equity Incentive Plans In 2015, the Company adopted the 2015 Equity Incentive Plan (the “2015 Plan”), in which shares of common stock of the Company are reserved for issuance of stock options to team members, directors, or consultants. The options generally vest 25% upon completion of one year and then ratably over 36 months. Options generally expire ten years from the date of grant. All these options qualify as equity settled awards and contain no performance conditions. In September 2021, in connection with the IPO, the board of directors and stockholders approved the 2021 Equity Incentive Plan (the “2021 Plan”) as a successor to the Company’s 2015 Plan (together the “Plans”). The 2021 Plan authorizes the award of both stock options, which are intended to qualify for tax treatment under Section 422 of the Internal Revenue Code, and nonqualified stock options, as well for the award of restricted stock awards (“RSAs”), stock appreciation rights (“SARs”), restricted stock units (“RSUs”), PSUs and stock bonus awards. Pursuant to the 2021 Plan, incentive stock options may be granted only to the Company’s team members. The Company may grant all other types of awards to its team members, directors, and consultants. The Company initially reserved 13,032,289 shares of its Class A common stock, plus any reserved shares of Class B common stock not issued or subject to outstanding grants under the 2015 Plan on the effective date of the 2021 Plan, for issuance as Class A common stock pursuant to awards granted under the 2021 Plan. The number of shares reserved for issuance under the 2021 Plan increases automatically on February 1 of each of the years from 2022 through 2031. The awards available for grant under the above Plans for the pe riods presented were as follows (in thousands): October 31, 2022 January 31, 2022 Available at beginning of period 18,248 4,796 Awards authorized 7,673 22,532 Options granted — (7,936) RSUs and PSUs granted (5,613) (3,290) RSUs and PSUs cancelled and forfeited 418 10 Options cancelled and forfeited 1,280 2,044 Options repurchased 62 92 Available at end of period 22,068 18,248 In the event that shares previously issued u nder the above Plans are reacquire d by the Company, such shares shall be added to the number of shares then available for issuance under the Plans. In the event that an outstanding stock option for any reason expires or is canceled, the shares allocable to the unexercised portion of su ch stock option will be added to the number of shares then available for issuance under the Plans. Both Plans allow the grantees to early exercise stock options. Stock Options, RSUs and PSUs The following table summarizes options activity under the Plans, and related information: Number of Stock Options Outstanding (in thousands) Weighted Average Exercise Price Weighted Average Remaining Years Aggregate Intrinsic value (in millions) Balances at January 31, 2022 17,146 $ 11.83 8.24 $ 894.8 Options granted — — Options exercised (1,993) 8.99 Options cancelled (28) 8.78 Options forfeited (1,252) 13.87 Balances at October 31, 2022 13,873 $ 12.05 7.17 $ 505.1 Options vested at October 31, 2022 7,109 $ 8.80 6.42 $ 281.9 Options vested and expected to vest at October 31, 2022 13,873 $ 12.05 7.17 $ 505.1 No options were granted during the three months ended October 31, 2022 and the weighted-average grant-date fair value per share of options granted was $12.74 for the three months ended October 31, 2021. The aggregate intrinsic value of options exercised during the three months ended October 31, 2022 and 2021 was $26.6 million and $108.6 million, respectively. The aggregate intrinsic value represents the difference between the exercise price and the fair value of the underlying common stock on the date of exercise. No options were granted during the nine months ended October 31, 2022 and the weighted-average grant-date fair value per share of options granted was $10.81 for the nine months ended October 31, 2021. The aggregate intrinsic value of options exercised during the nine months ended October 31, 2022 and 2021 was $86.5 million and $269.9 million, respectively. The aggregate intrinsic value represents the difference between the exercise price and the fair value of the underlying common stock on the date of exercise. As of October 31, 2022 and January 31, 2022, approximately $53.6 million and $80.3 million, respectively, of total unrecognized compensation cost was related to stock options granted, that is expected to be recognized over a weighted-average period of 2.3 years and 2.7 years, respectively. The expected stock compensation expense remaining to be recognized reflects only outstanding stock awards as of the periods presented, and assumes no forfeitures. The following table summarizes the Company’s restricted stock units activity (in thousands): Number of Shares (1) Weighted- Balances at January 31, 2022 272 $ 82.11 Granted 5,248 53.15 Vested (558) 56.66 Canceled/forfeited (371) 56.28 Balances at October 31, 2022 4,591 $ 54.10 (1) The table above does not include 3 million RSUs issued to the Company’s founder and the CEO described below. These RSUs are grants of shares of the Company’s common stock, the vesting of which is based on the requisite service requirement. Generally, the Company’s RSUs are subject to forfeiture and are expected to vest over two As of October 31, 2022 and January 31, 2022, approximately $237.0 million and $21.5 million, respectively, of total unrecognized compensation cost was related to restricted stock units granted to team members other than the CEO, that is expected to be recognized over a weighted-average period of 3.3 years and 3.9 years, respectively. The expected stock compensation expense remaining to be recognized reflects only outstanding stock awards as of the periods presented, and assumes no forfeitures. In June 2022, the Company granted 0.4 million PSUs to senior members of its management team subject to revenue performance condition and service conditions. The number of awards granted represents 100% of the target goal; under the terms of the awards, the recipient may earn between 0% and 200% of the original grant. The performance condition is set to be achieved in fiscal 2025 and the service condition in the calendar year 2025. The Company recorded $1.3 million and $2.0 million of stock-based compensation expense related to PSUs during the three and nine months ended October 31, 2022, respectively. As of October 31, 2022, unrecognized stock-based compensation expense related to these PSUs was $18.0 million to be recognized over a period of 3.1 years. CEO Performance Award In May 2021, the Company granted 3 million RSUs tied to its Class B common stock to Mr. Sijbrandij, the Company’s co-founder and CEO, with an estimated aggregate grant date fair value of $8.8 million. The Company recorded $0.4 million and $1.2 million of stock-based compensation expense related to the CEO RSUs during the three and nine months ended October 31, 2022, respectively. The Company recorded $0.8 million of stock-based compensation expense related to the CEO RSUs during each of the three and nine months ended October 31, 2021. As of October 31, 2022, unrecognized stock-based compensation expense related to these RSUs was $6.4 million which will be recognized over the remaining derived service period of the respective tranches which ranges from 2 to 7 years. 2021 Employee Stock Purchase Plan (“ESPP”) In September 2021, the Company’s board of directors and its stockholders approved the 2021 Employee Stock Purchase Plan (“ESPP”) to enable eligible team members to purchase shares of the Company’s Class A common stock with accumulated payroll deductions and provides a 15% purchase price discount of the fair market value of the Company’s Class A common stock on the IPO date or purchase date, whichever is lower. The 2021 ESPP also provides up to a 27-month look-back period with four purchase dates in May and November of each year, and the first purchase occurred in May 2022. If the closing price of the Company’s Class A common stock on the first day of the current offering period is higher than the price on the last day of any applicable purchase period, the ESPP requires the price to be reset based on the lower fair market value and the offering period to be rolled over for a new period of 24 months. This reset and rollover was triggered on the May 31, 2022 purchase date. The original offering period commencing on the IPO date through November 30, 2023 was modified to a new offering period commencing June 1, 2022 through May 31, 2024 and the ESPP price was reset based on the closing price of the Company’s Class A common stock on May 31, 2022. In accordance with ASC 718, Stock-Based Compensation , the modification in respect of the reset of the ESPP price and rollover resulted in an incremental charge of stock-based compensation expense of $1.0 million and $1.7 million during the three and nine months ended October 31, 2022, respectively. The remaining modification charge of $7.7 million will be recognized over the new offering period. The following table summarizes assumptions used in estimating the fair value of the ESPP for the offering period in effect using the Black-Scholes option-pricing model: Nine Months Ended October 31, 2022 Risk-free interest rate 1.62% - 2.63% Volatility 44.95% - 52.76% Expected term (in years) 0.5 - 2.0 Dividend yield —% The Company record ed $5.3 million and $19.4 million of stock-based compensation expense related to the ESPP during the three and nine months ended October 31, 2022, respectively. As of October 31, 2022, approximately $24.9 million of total unrecognized compensation cost was related to the ESPP that is expected to be recognized over 1.6 years. In May 2022, the Company issued 0.3 million shares of Class A common stock to team members through the ESPP. Stock-Based Compensation Expense The Company recognized stock-based compensation expense as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Cost of revenue $ 1,248 $ 331 $ 3,623 $ 722 Research and development 10,030 2,147 26,405 4,653 Sales and marketing 12,905 2,562 34,807 5,688 General and administrative 9,525 3,539 24,091 6,179 Total stock-based compensation expense (1) $ 33,708 $ 8,579 $ 88,926 $ 17,242 (1) The table above includes stock-based compensation of JiHu. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion. The corporate income tax benefit recognized in the condensed consolidated statements of operations for stock-based compensation expense was $2.6 million and $5.8 million for the three and nine months ended October 31, 2022, respectively, and not material for the three and nine months ended October 31, 2021.

Joint Venture and Equity Method

Joint Venture and Equity Method Investment	9 Months Ended
Joint Venture and Equity Method Investment	Oct. 31, 2022
Noncontrolling Interest [Abstract]
Joint Venture and Equity Method Investment	11. Joint Venture and Equity Method Investment Joint Venture In February 2021, the Company along with Sequoia CBC Junyuan (Hubei) Equity Investment Partnership (Limited Partnership) and Suzhou Gaocheng Xinjian Equity Investment Fund Partnership (Limited Partnership) executed an investment agreement (the “Investment Agreement”) to establish GitLab Information Technology (Hubei) Co., LTD (“JiHu”), a legal entity in the People’s Republic of China. The Company accounted for JiHu as a variable interest entity and consolidated the entity in accordance with ASC Topic 810, Consolidation . On March 29, 2022, JiHu closed its Series A-1 round of common stock financing where investors contributed $27.7 million, net of issuance costs. On July 1, 2022, JiHu closed its Series A-2 round of common stock financing where investors contributed $22.8 million, net of issuance costs. On September 7, 2022, JiHu closed its Series A-3 round of financing with an external investor who contributed $4.1 million, net of issuance costs. The Company accounted for these funding events as equity transactions with the carrying amount of the non-controlling interest adjusted to reflect the change in the ownership interest in JiHu, and the difference was recognized in the Company’s additional paid-in capital. Subsequent to the closing of the rounds, the Company retains control over JiHu with its equity stake reduced from 72% to 55%. In March 2022, one of the potential investors who could not participate in the Series A-1 financing round provided a $2.9 million loan to JiHu as an advance pending a capital contribution. The loan was repayable within ten business days of receipt of capital contribution from the investor. JiHu received an equity contribution from this investor during the Series A-2 round and repaid the loan in full in July 2022. During the nine months ended October 31, 2022, the board of directors of JiHu approved an employee stock option plan (“JiHu ESOP”) for its employees. During the three and nine months ended October 31, 2022, the Company recognized $2.5 million and $5.5 million stock-based compensation expense related to JiHu ESOP, respectively. As of October 31, 2022, approximately $15.8 million of total unrecognized compensation cost was related to the JiHu ESOP that is expected to be recognized over 3.5 years. The Company considers the RSUs and stock option awards granted pursuant to the JiHu ESOP as potentially dilutive equity instruments that will result in dilution of the Company’s stake in JiHu upon vesting of such award (or, in the case of option awards granted pursuant to the JiHu ESOP, upon vesting and subsequent exercise into shares of JiHu common stock). Any such dilution will be accounted for as an equity transaction. Until such awards granted pursuant to the JiHu ESOP are vested (or, in the case of option awards, vested and ultimately exercised into shares of JiHu common stock), the Company will continue to record the recognized stock-compensation expense of JiHu as part of the noncontrolling interest. Selected financial information of JiHu, post intercompany eliminations, is as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Revenue $ 1,275 $ 265 $ 3,388 $ 297 Cost of revenue 481 243 1,193 604 Gross profit (loss) 794 22 2,195 (307) Operating expenses: Sales and marketing 1,999 780 5,251 1,630 Research and development 1,898 499 4,735 1,376 General and administrative 3,070 621 7,363 1,984 Total operating expenses 6,967 1,900 17,349 4,990 Loss from operations (6,173) (1,878) (15,154) (5,297) Interest income 193 — 403 — Other income, net 1,452 7 2,464 8 Net loss before income taxes (4,528) (1,871) (12,287) (5,289) Net loss $ (4,528) $ (1,871) $ (12,287) $ (5,289) Net loss attributable to noncontrolling interest $ (2,010) $ (521) $ (4,997) $ (1,443) October 31, 2022 January 31, 2022 Cash and cash equivalents $ 55,573 $ 14,198 Property and equipment, net 964 769 Other assets 2,965 2,765 Total assets $ 59,502 $ 17,732 Total liabilities $ 4,527 $ 3,663 Equity Method Investment In April 2021, the Company reorganized Meltano Inc. (“Meltano”), which started as an internal project within the Company in July 2018, into a separate legal entity. The entity was funded by the Company’s contribution of intellectual property with the fair value of approximately $0.4 million and a preferred stock financing from third parties of $4.2 million, representing 12% ownership on a fully diluted basis. On April 4, 2022, Meltano closed its Series Seed-2 round of preferred stock financing and raised $7.2 million. Pursuant to this transaction, the board composition of Meltano changed and the Company no longer has the power to appoint the majority of the board of directors of Meltano. Consequently, despite having majority voting rights at the stockholder level, the Company no longer has control over Meltano. The loss of control of a majority owned subsidiary resulted in the deconsolidation of net assets of $9.4 million and non-controlling interest of Meltano of $11.3 million, recognition of retained interest at fair value of $15.9 million , and a gain of $17.8 million recorded in other income (expense), net during the nine months ended October 31, 2022 . The fair value of retained interest was determined using Option Pricing Model (“OPM”) Backsolve approach based on the most recent funding round of preferred stock. As of the date of the loss of control, the basis difference between the fair value of investment in Meltano and the Company’s share in the net assets of Meltano was attributed to equity method goodwill. Effective April 4, 2022, the Company accounts for this investment under the equity method and has recorded $13.6 million in “equity method investment” on its condensed consolidated balance sheet as of October 31, 2022. During the three and nine months ended October 31, 2022, the Company recognized a loss from equity method investment of $0.8 million and $1.8 million, net of tax on the condensed consolidated statements of operations, respectively. As of October 31, 2022, the Company owns

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Oct. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	12. Income Taxes For the three and nine months ended October 31, 2022, the Company recorded income tax expense of $0.1 million and $2.5 million on pretax losses of $49.6 million and $134.3 million, respectively. The income tax expense for the three and nine months ended October 31, 2022 was primarily due to the Company's foreign and domestic operations and the establishment of a deferred tax liability relating to the deconsolidation of a majority-owned entity, Meltano, and simultaneous establishment of the Company's equity method investment. For the three and nine months ended October 31, 2021, the Company recorded income tax benefit of $0.9 million and income tax expense of $1.4 million on pretax losses of $42.6 million and $109.4 million, respectively. The income tax benefit for the three months ended October 31, 2021 was primarily related to an increase in domestic losses from operations. The income tax expense for the nine months ended October 31, 2021 was primarily related to tax liability from the Company's foreign and domestic operations. The increase in income tax expense for the three months ended October 31, 2022 as compared to the prior year is largely attributable to increased profit from domestic and certain foreign operations. The increase in income tax expense for the nine months ended October 31, 2022 as compared to the prior year is largely attributable to a deferred tax expense from the Company's equity investment in Meltano. The Company's provision for income taxes is based on its worldwide estimated annualized effective tax rate, except for jurisdictions for which a loss is expected for the year and no benefit can be realized for those losses, jurisdictions for which forecasted pre-tax income or loss cannot be estimated, and the tax effect of discrete items occurring during the period. The tax provision for jurisdictions for which a forecast cannot be estimated is based on actual taxes and tax reserves for the quarter. Under the provisions of ASC 740, Income Taxes , the determination of the Company’s ability to recognize its deferred tax asset requires an assessment of both negative and positive evidence when determining the Company’s ability to recognize its deferred tax assets. The Company determined that it was not more likely than not that the Company could recognize certain deferred tax assets. Evidence evaluated by the Company included operating results during the most recent three-year period and future projections, with more weight given to historical results than expectations of future profitability, which are inherently uncertain. Certain entities’ net losses in recent periods represented sufficient negative evidence to require a valuation allowance against its net deferred tax assets. This valuation allowance will be evaluated periodically and could be reversed partially or totally if business results have sufficiently improved to support realization of deferred tax assets. As of October 31, 2022, unrecognized tax benefits approximated $5.6 million, of which $0.8 million would affect the effective tax rate if recognized. The Company is unable to reasonably estimate the timing of the long-term payments or the amount by which the liability will increase or decrease. It is the Company’s policy to classify accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. For the three and nine months ended October 31, 2022 and 2021, the Company recognized an insignificant amount of interest and penalties related to unrecognized tax benefits. Accrued interest and penalties were $0.2 million as of October 31, 2022 and $0.1 million as of January 31, 2022.

Net Loss per Share

Net Loss per Share	9 Months Ended
Net Loss per Share	Oct. 31, 2022
Earnings Per Share [Abstract]
Net Loss per Share	13. Net Loss per Share The following table sets forth basic and diluted loss per share for each of the periods presented (in thousands, except per share data): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Numerator: Net loss attributable to GitLab $ (48,455) $ (41,227) $ (133,578) $ (109,353) Denominator: Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted 148,883 67,018 147,812 57,789 Net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted $ (0.33) $ (0.62) $ (0.90) $ (1.89) Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands): October 31, 2022 January 31, 2022 Shares subject to outstanding common stock options 13,873 17,146 Unvested RSUs in connection with business combination 15 16 Unvested early exercised stock options 268 714 Unvested RSUs and PSUs 7,909 3,264 Shares subject to the 2021 ESPP 135 256 Total 22,200 21,396

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Oct. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	14. Commitments and Contingencies Contractual Obligations and Commitments The Company’s contractual commitments relate mainly to third-party non-cancellable hosting infrastructure agreements and subscription arrangements used in the ordinary course of business. There have been no material changes to the contractual obligations with a term of 12 months or longer since the filing of the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2022, except for a non-cancelable 3-year hosting infrastructure arrangement for an aggregate consideration of $7.4 million, a non-cancelable 3-year software subscription arrangement for an aggregate consideration of $2.3 million. See “Note 14. Commitments and Contingencies” in the Company’s Annual Report on Form 10-K filed with the SEC on April 8, 2022 for further information. Loss Contingencies In accordance with ASC 450, Loss Contingencies, the Company accrues for contingencies when losses become probable and reasonably estimable. If applicable, the Company accrues receivables for probable insurance or other third-party recoveries. Accordingly, the Company has recorded an estimated liability related to certain labor matters regarding its use o f contractors in certain foreign countries. As of October 31, 2022 and January 31, 2022 , the estimated liability relating to these matters was $2.5 million and $2.6 million, respectively. Warranties and Indemnifications The Company enters into service level agreements with customers which warrant defined levels of uptime and support response times and permit those customers to receive credits for prepaid amounts in the event that those performance and response levels are not met. To date, the Company has not experienced any significant failures to meet defined levels of performance and response. In connection with the service level agreements, the Company has not incurred any significant costs and has not accrued any liabilities in the condensed consolidated financial statements. In the ordinary course of business, the Company enters into contractual arrangements under which the Company agrees to provide indemnification of varying scope and terms to business partners and other parties with respect to certain matters, including, but not limited to, losses arising out of the breach of such agreements, intellectual property infringement claims made by third parties, and other liabilities relating to or arising from the Company’s platform or the Company’s acts or omissions. In these circumstances, payment may be conditional on the other party making a claim pursuant to the procedures specified in the particular contract. Further, the Company’s obligations under these agreements may be limited in terms of time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments. In addition, the Company has agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines, and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person’s service as a director or officer, including any action by the Company, arising out of that person’s services as the Company’s director or officer or that person’s services provided to any other company or enterprise at the Company’s request. The Company maintains director and officer insurance coverage that may enable the Company to recover a portion of any future amounts paid. Legal Proceedings The Company is, and from time to time, may become involved in legal proceedings or be subject to claims arising in the ordinary course of its business. The Company is not presently a party to any legal proceedings that in the opinion of management, if determined adversely to the Company, would individually or taken together have a material adverse effect on its business, financial condition or operating results.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP.
Fiscal Year	Fiscal Year The Company's fiscal year ends on January 31. For example, references to fiscal 2023 and 2022 refer to the fiscal year ending January 31, 2023 and the fiscal year ended January 31, 2022, respectively.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates include, but are not limited to, allocation of revenue to the license element in the Company's self-managed subscriptions, estimating the amortization period for capitalized costs to obtain a contract, allowance for doubtful accounts, stock-based compensa tion expense, fair value of contingent consideration, fair valuation of retained interest in an investee on loss of control, valuation allowance for deferred income taxes and valuation of intangibles assets . The Company bases these estimates on historical and anticipated results, tre nds, and various other assumptions, including the impact of the COVID-19 pandemic, that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates. The novel coronavirus, or COVID-19, pandemic has created, and may continue to create, significant uncertainty in macroeconomic conditions. The global impact of COVID-19 continues to rapidly evolve, and the Company will continue to monitor the situation and the effects on its business and operations closely. The Company does not yet know the full extent of potential impacts on its business or operations or on the global economy as a whole, particularly if the COVID-19 pandemic continues and persists for an extended period of time.
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include 100% of the accounts of wholly owned subsidiaries and a variable interest entity for which our Company is the primary beneficiary. The
Short-Term Investments - Marketable Securities	Short-Term Investments - Marketable Securities The Company classifies its marketable securities with stated maturities of three months and greater as short-term investments due to its ability to use these securities to support the Company’s current operations. As of October 31, 2022, all short-term investments are classified as available-for-sale and are reported at fair value, which is based on quoted market prices for such securities, if available, or based on quoted market prices of financial instruments with similar characteristics. Unrealized gains and losses are recorded as a separate component of other comprehensive loss, net of tax. Realized gains and losses on available-for-sale securities are recognized upon sale and are included in other income (expense), net in the condensed consolidated statements of operations. The Company periodically reviews its available-for-sale securities to determine if there has been an other-than-temporary decline in fair value. Factors considered in determining whether a loss is other-than-temporary include, but are not limited to: the length of time and extent a security’s fair value has been below its cost, the financial condition and near-term prospects of the investee, the credit quality of the security’s issuer, likelihood of recovery and the Company’s intent and ability to hold the security for a period of time sufficient to allow for any anticipated recovery in value. No changes in fair value due to impairment have been recorded in earnings for available-for-sale securities during the periods presented.
Equity Method Investments	Equity Method Investment The Company applies the equity method of accounting to investments when it has significant influence, but not controlling interest in the investee. The Company’s equity method investments are reported at cost and adjusted each period for its proportionate share of the investee’s income or loss. The cost on initial recognition of retained interest in an erstwhile subsidiary is based on fair value on the date of loss of control. The Company’s proportionate share of the net loss resulting from the investment is reported under loss from equity method investment, net of tax in our condensed consolidated statements of operations. The carrying value of the Company’s equity method investments is reported in equity method investment in the condensed consolidated balance sheets. The Company assesses investments for impairment whenever events or changes in circumstances indicate that the carrying value of an investment may not be recoverable.
Stock-Based Compensation	Stock-Based Compensation Our PSUs issued to the senior members of the management team are subject to a revenue performance condition and service conditions. The number of PSUs that will ultimately vest will depend on the revenue achieved by the Company in fiscal 2025 relative to the defined target. The fair value of PSUs is measured at the market price of the Company’s Class A common stock on the date of grant and compensation costs related to these awards are recognized on a graded-vesting method over the requisite service period.
Recently Adopted Accounting Standards and Recently Issued Accounting Standards Not Yet Adopted	Recently Adopted Accounting Standards In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which simplifies the accounting for income taxes by eliminating some exceptions to the general approach in ASC 740, Income Taxes in order to reduce cost and complexity of its application. The Company adopted ASU 2019-12 as of February 1, 2022 with no material impact. Recently Issued Accounting Standards Not Yet Adopted In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820) (“Topic 820”): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (“ASU 2022-03”). ASU 2022-03 clarifies the guidance in Topic 820 that a contractual restriction on the sale of an equity security should not be considered in measuring fair value, and introduces new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. For public companies, the amendments to ASU 2022-03 are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2024, and interim periods within those fiscal years. The adoption of ASU 2022-03 is not expected to have a material effect on the Company’s condensed consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) (“Topic 842”). Topic 842 supersedes the lease requirements in ASC Topic 840, Leases . Under Topic 842, lessees are required to recognize assets and liabilities on the condensed consolidated balance sheet for most leases and provide enhanced disclosures. Leases will continue to be classified as either finance or operating. For public companies, Topic 842 is effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. The Company has elected to use the extended transition period that allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies under the JOBS Act. For as long as the Company remains an “emerging growth company,” the new guidance is effective for annual reporting periods beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The adoption of ASU 2016-02 is not expected to have a material effect on the Company’s condensed consolidated financial statements. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost. ASU 2016-13 replaces the existing incurred loss impairment model with an expected loss methodology, which will result in more timely recognition of credit losses. Since the Company follows private company’s adoption timelines, this new guidance is effective for the Company for its fiscal year beginning February 1, 2023. The Company is currently evaluating the effect of the adoption of ASU 2016-13 on its condensed consolidated financial statements. The effect will largely depend on the composition and credit quality of the Company's portfolio of financial assets and the economic conditions at the time of adoption.
Fair Value of Financial Instruments	The Company determines fair value based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value assumes that the transaction to sell the asset or transfer the liability occurs in the principal or most advantageous market for the asset or liability and establishes that the fair value of an asset or liability shall be determined based on the assumptions that market participants would use in pricing the asset or liability. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the fair value measurement. The fair value hierarchy prioritizes the inputs into three levels that may be used to measure fair value: Level 1: Inputs are unadjusted quoted prices in active markets for identical assets or liabilities. Level 2: Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3: Inputs are unobservable based on the Company’s own assumptions used to measure assets and liabilities at fair value. The inputs require significant management judgment or estimation. The fair value of the Company’s Level 1 financial instruments, such as money market funds which are traded in active markets, is based on quoted market prices for identical instruments. The fair value of the Company’s Level 2 financial instrumen ts such as commercial paper, corporate debt and U.S. government securities are obtained from an independent pricing service, which may use inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security that may not be actively traded. The Company’s marketable securities are held by custodians who obtain investment prices from a third-party pricing provider that incorporates standard inputs in various asset price models.

Revenues (Tables)

Revenues (Tables)	9 Months Ended
Revenues (Tables)	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table shows the components of revenues and their respective percentages of total revenue for the periods indicated (in thousands, except percentages): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Subscription—self-managed and SaaS $ 98,435 87 % $ 59,774 89 % $ 264,294 88 % $ 156,542 90 % Subscription—self-managed 72,720 64 47,215 70 199,335 66 124,742 72 SaaS 25,715 23 12,559 19 64,959 22 31,800 18 License—self-managed and other $ 14,546 13 % $ 7,026 11 % $ 37,135 12 % $ 18,315 10 % License—self-managed 11,860 11 5,314 8 30,646 10 13,757 8 Professional services and other 2,686 2 1,712 3 6,489 2 4,558 2 Total revenue $ 112,981 100 % $ 66,800 100 % $ 301,429 100 % $ 174,857 100 %
Revenue from External Customers by Geographic Areas	The following table summarizes the Company’s total revenue by geographic location based on the region of the Company’s contracting entity, which may be different than the region of the customer (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 United States $ 94,942 $ 56,706 $ 251,339 $ 147,226 Europe 15,547 9,165 43,285 24,631 Asia Pacific 2,492 929 6,805 3,000 Total revenue $ 112,981 $ 66,800 $ 301,429 $ 174,857

Cash, Cash Equivalents and Sh_2

Cash, Cash Equivalents and Short-Term Investments (Tables)	9 Months Ended
Cash, Cash Equivalents and Short-Term Investments (Tables)	Oct. 31, 2022
Cash and Cash Equivalents [Abstract]
Schedule of Short Term Investments	The following table summarizes the Company’s cash, cash equivalents and short-term investments by category (in thousands): As of October 31, 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Cash and cash equivalents: Cash $ 279,997 $ — $ — $ 279,997 Money market funds 71,218 — — 71,218 U.S. Treasury securities 14,978 — (1) 14,977 U.S. Agency securities 5,981 — (4) 5,977 Total cash and cash equivalents $ 372,174 $ — $ (5) $ 372,169 Short-term investments: Commercial paper 39,112 — (226) 38,886 Corporate debt securities 49,338 — (852) 48,486 Municipal bonds 1,981 — (30) 1,951 Foreign government bonds 2,198 — (42) 2,156 U.S. Agency securities 36,256 — (492) 35,764 U.S. Treasury securities 433,737 — (5,397) 428,340 Total short-term investments $ 562,622 $ — $ (7,039) $ 555,583
Schedule of Unrealized Losses Cash Equivalents and Short Term Investment	The following table summarizes unrealized losses on our cash equivalents and short-term investments by category that have been in a continuous unrealized loss position for less than 12 months as of the periods presented (in thousands): Carrying Value Gross Unrealized Losses October 31, 2022 U.S. Agency securities $ 41,741 $ (496) Commercial paper 33,886 (226) Corporate debt securities 48,486 (852) Municipal bonds 1,951 (30) Foreign government bonds 2,156 (42) U.S. Treasury securities 438,318 (5,398) Total cash equivalents and short-term investments $ 566,538 $ (7,044)
Schedule of Short Term Investments by Contractual Maturity	The following table classifies the Company’s short-term investments by contractual maturities (in thousands): October 31, 2022 January 31, 2022 Amortized cost Fair Value Amortized cost Fair Value Due within 1 year $ 433,053 $ 428,649 $ 50,031 $ 50,031 Due between 1 year to 2 years 129,569 126,934 — — Total $ 562,622 $ 555,583 $ 50,031 $ 50,031

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Financial Assets Measured at Fair Value on Recurring Basis	Financial assets measured at fair value on a recurring basis are summarized below (in thousands): Level 1 Level 2 Level 3 Fair Value October 31, 2022 (1) Cash equivalents: Money market funds $ 71,218 $ — $ — $ 71,218 U.S. Agency securities — 5,977 — 5,977 U.S. Treasury securities — 14,977 — 14,977 Short-term investments: Commercial paper — 38,886 — 38,886 Corporate debt securities — 48,486 — 48,486 Municipal bonds — 1,951 — 1,951 Foreign government bonds — 2,156 — 2,156 U.S. Agency securities — 35,764 — 35,764 U.S. Treasury securities — 428,340 — 428,340 Total $ 71,218 $ 576,537 $ — $ 647,755 (1) Exclu

Supplemental Financial Statem_2

Supplemental Financial Statement Information (Tables)	9 Months Ended
Supplemental Financial Statement Information (Tables)	Oct. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Other Current Assets	Prepaid expenses and other current assets consisted of the following (in thousands): October 31, 2022 January 31, 2022 Prepaid software subscriptions $ 7,028 $ 3,950 Prepaid advertising costs 737 722 Security and other deposits 1,005 981 Prepaid insurance 76 4,309 Prepaid income taxes 3,893 3,168 Restricted cash (1) 2,500 — Interest receivable 1,485 49 Prepaid expenses for the Company’s events 1,093 266 Other prepaid expenses 1,818 1,834 Other current assets 819 265 Total prepaid expense and other current assets $ 20,454 $ 15,544 (1) Refer to “Note 7. Business Combination”.
Property, Plant and Equipment	Property and equipment, net of the following (in thousands): October 31, 2022 January 31, 2022 Computer and office equipment $ 7,315 $ 3,049 Leasehold improvements 709 765 Others 259 — 8,283 3,814 Less: Accumulated depreciation (1) (2,723) (543) Total property and equipment, net (1) $ 5,560 $ 3,271 (1) The amounts in the table above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying property and equipment.
Schedule of Other Assets, Noncurrent	Other assets consisted of the following (in thousands): October 31, 2022 January 31, 2022 Security and other deposits $ 2,956 $ 2,832 Restricted cash (1) — 2,500 Deferred software implementation costs 1,088 969 Other long-term assets 759 850 Total other long-term assets $ 4,803 $ 7,151 (1) Refer to “Note 7. Business Combination”.
Schedule of Accrued Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): October 31, 2022 January 31, 2022 Accrued expenses $ 10,956 $ 8,605 Income taxes payable 1,646 319 ESPP employee contributions 4,406 6,557 Indirect taxes payable 1,725 4,044 Acquisition related contingent cash consideration (1) — 3,029 Acquisition related consideration withheld in escrow (1) 2,500 — Customer refunds 2,467 2,017 Other current liabilities 53 — Total accrued expenses and other current liabilities $ 23,753 $ 24,571 (1) Refer to “Note 7. Business Combination”.
Schedule of Accounts Payable and Accrued Liabilities	Accrued compensation and benefits consisted of the following (in thousands): October 31, 2022 January 31, 2022 Accrued commissions $ 6,841 $ 8,417 Payroll taxes payable 2,073 14,506 Other accrued team member related payables 7,802 9,897 Total accrued compensation and benefits $ 16,716 $ 32,820
Other Noncurrent Liabilities	Other long-term liabilities consisted of the following (in thousands): October 31, 2022 January 31, 2022 Early exercised options liability $ 2,581 $ 6,837 Acquisition related contingent cash consideration (1) 5,105 4,929 Acquisition related consideration withheld in escrow (1) — 2,500 Deferred tax liabilities 1,028 379 Contingent liability for labor matters 2,493 2,573 Long term taxes payable 737 784 Other long-term liabilities 181 — Total other long-term liabilities $ 12,125 $ 18,002 (1) Refer to “Note 7. Business Combination”.
Other Income (Expense), Net	Other income (expense), net consisted of the following (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Gain from deconsolidation of Meltano Inc. (1) $ — $ — $ 17,798 $ — Foreign exchange gains (losses), net 2,855 (9,831) 5,361 (19,703) Other expense, net (194) (378) (550) (1,549) Total other income (expense), net $ 2,661 $ (10,209) $ 22,609 $ (21,252) (1) Refer to “Note 11. Joint Venture and Equity Method Investment”.

Business Combination (Tables)

Business Combination (Tables)	9 Months Ended
Business Combination (Tables)	Oct. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of Business Acquisitions, by Acquisition	The transaction was accounted for as a business combination. The acquisition date fair value of the consideration transferred consisted of the following (in thousands): Cash consideration $ 2,970 Fair value of common stock issued on closing 959 Contingent common stock consideration (classified under additional paid-in capital) 1,754 Contingent cash consideration (paid as of October 31, 2022) 3,007 Contingent cash consideration (classified under other long-term liabilities as of October 31, 2022) 4,893 Total consideration $ 13,583

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Net (Tables)	9 Months Ended
Goodwill and Intangible Assets, Net (Tables)	Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The carrying amount of goodwill was as follows (in thousands): Carrying Amount Balance as of October 31, 2022 and January 31, 2022 $ 8,145
Schedule of Finite-Lived Intangible Assets	Intangible assets, net consisted of the following (in thousands): October 31, 2022 Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination $ 6,200 $ (1,880) $ 4,320 2.1 Developed technology from asset acquisitions (1) 1,249 (1,085) 164 0.5 Total $ 7,449 $ (2,965) $ 4,484 January 31, 2022 Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination $ 6,200 $ (334) $ 5,866 2.8 Developed technology from asset acquisitions (1) 1,402 (983) 419 1.3 Total $ 7,602 $ (1,317) $ 6,285 (1) The amounts in the tables above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying intangibles.
Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination	As of October 31, 2022 , future amortization expense related to the intangibles assets is expected to be as follows (in thousands): Fiscal Years 2023 $ 591 2024 2,166 2025 1,727 Total future amortization $ 4,484

Equity (Tables)

Equity (Tables)	9 Months Ended
Equity (Tables)	Oct. 31, 2022
Equity [Abstract]
Schedule of Stock Reserved For Future Issuance	The Company had shares of common stock reserved for future issuance as follows (in thousands): October 31, 2022 January 31, 2022 Class A and Class B common stock Options issued and outstanding 13,873 17,146 Shares available for issuance under Equity Incentive Plans 22,068 18,248 RSUs and PSUs issued and outstanding 7,909 3,280 Shares reserved for issuance to charitable organizations 1,636 1,636 2021 ESPP 4,451 3,271 Total 49,937 43,581
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award	The awards available for grant under the above Plans for the pe riods presented were as follows (in thousands): October 31, 2022 January 31, 2022 Available at beginning of period 18,248 4,796 Awards authorized 7,673 22,532 Options granted — (7,936) RSUs and PSUs granted (5,613) (3,290) RSUs and PSUs cancelled and forfeited 418 10 Options cancelled and forfeited 1,280 2,044 Options repurchased 62 92 Available at end of period 22,068 18,248
Share-based Payment Arrangement, Option, Activity	The following table summarizes options activity under the Plans, and related information: Number of Stock Options Outstanding (in thousands) Weighted Average Exercise Price Weighted Average Remaining Years Aggregate Intrinsic value (in millions) Balances at January 31, 2022 17,146 $ 11.83 8.24 $ 894.8 Options granted — — Options exercised (1,993) 8.99 Options cancelled (28) 8.78 Options forfeited (1,252) 13.87 Balances at October 31, 2022 13,873 $ 12.05 7.17 $ 505.1 Options vested at October 31, 2022 7,109 $ 8.80 6.42 $ 281.9 Options vested and expected to vest at October 31, 2022 13,873 $ 12.05 7.17 $ 505.1
Schedule of Restricted Stock Units Activity	The following table summarizes the Company’s restricted stock units activity (in thousands): Number of Shares (1) Weighted- Balances at January 31, 2022 272 $ 82.11 Granted 5,248 53.15 Vested (558) 56.66 Canceled/forfeited (371) 56.28 Balances at October 31, 2022 4,591 $ 54.10
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The following table summarizes assumptions used in estimating the fair value of the ESPP for the offering period in effect using the Black-Scholes option-pricing model: Nine Months Ended October 31, 2022 Risk-free interest rate 1.62% - 2.63% Volatility 44.95% - 52.76% Expected term (in years) 0.5 - 2.0 Dividend yield —%
Share-based Payment Arrangement, Expensed and Capitalized, Amount	The Company recognized stock-based compensation expense as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Cost of revenue $ 1,248 $ 331 $ 3,623 $ 722 Research and development 10,030 2,147 26,405 4,653 Sales and marketing 12,905 2,562 34,807 5,688 General and administrative 9,525 3,539 24,091 6,179 Total stock-based compensation expense (1) $ 33,708 $ 8,579 $ 88,926 $ 17,242 (1) The table above includes stock-based compensation of JiHu. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Joint Venture and Equity Meth_2

Joint Venture and Equity Method Investment (Tables)	9 Months Ended
Joint Venture and Equity Method Investment (Tables)	Oct. 31, 2022
Noncontrolling Interest [Abstract]
Schedule of Variable Interest Entities	Selected financial information of JiHu, post intercompany eliminations, is as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Revenue $ 1,275 $ 265 $ 3,388 $ 297 Cost of revenue 481 243 1,193 604 Gross profit (loss) 794 22 2,195 (307) Operating expenses: Sales and marketing 1,999 780 5,251 1,630 Research and development 1,898 499 4,735 1,376 General and administrative 3,070 621 7,363 1,984 Total operating expenses 6,967 1,900 17,349 4,990 Loss from operations (6,173) (1,878) (15,154) (5,297) Interest income 193 — 403 — Other income, net 1,452 7 2,464 8 Net loss before income taxes (4,528) (1,871) (12,287) (5,289) Net loss $ (4,528) $ (1,871) $ (12,287) $ (5,289) Net loss attributable to noncontrolling interest $ (2,010) $ (521) $ (4,997) $ (1,443) October 31, 2022 January 31, 2022 Cash and cash equivalents $ 55,573 $ 14,198 Property and equipment, net 964 769 Other assets 2,965 2,765 Total assets $ 59,502 $ 17,732 Total liabilities $ 4,527 $ 3,663

Net Loss per Share (Tables)

Net Loss per Share (Tables)	9 Months Ended
Net Loss per Share (Tables)	Oct. 31, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth basic and diluted loss per share for each of the periods presented (in thousands, except per share data): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Numerator: Net loss attributable to GitLab $ (48,455) $ (41,227) $ (133,578) $ (109,353) Denominator: Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted 148,883 67,018 147,812 57,789 Net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted $ (0.33) $ (0.62) $ (0.90) $ (1.89)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands): October 31, 2022 January 31, 2022 Shares subject to outstanding common stock options 13,873 17,146 Unvested RSUs in connection with business combination 15 16 Unvested early exercised stock options 268 714 Unvested RSUs and PSUs 7,909 3,264 Shares subject to the 2021 ESPP 135 256 Total 22,200 21,396

Revenues - Disaggregation of Re

Revenues - Disaggregation of Revenue by Product and Service (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Disaggregation of Revenue [Line Items]
Total revenue	$ 112,981	$ 66,800	$ 301,429	$ 174,857
Revenue from Contract with Customer, Product and Service Benchmark \| Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	100%	100%	100%	100%
Subscription—self-managed and SaaS
Disaggregation of Revenue [Line Items]
Total revenue	$ 98,435	$ 59,774	$ 264,294	$ 156,542
Subscription—self-managed and SaaS \| Revenue from Contract with Customer, Product and Service Benchmark \| Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	87%	89%	88%	90%
Subscription—self-managed
Disaggregation of Revenue [Line Items]
Total revenue	$ 72,720	$ 47,215	$ 199,335	$ 124,742
Subscription—self-managed \| Revenue from Contract with Customer, Product and Service Benchmark \| Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	64%	70%	66%	72%
SaaS
Disaggregation of Revenue [Line Items]
Total revenue	$ 25,715	$ 12,559	$ 64,959	$ 31,800
SaaS \| Revenue from Contract with Customer, Product and Service Benchmark \| Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	23%	19%	22%	18%
License—self-managed and other
Disaggregation of Revenue [Line Items]
Total revenue	$ 14,546	$ 7,026	$ 37,135	$ 18,315
License—self-managed and other \| Revenue from Contract with Customer, Product and Service Benchmark \| Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	13%	11%	12%	10%
License—self-managed
Disaggregation of Revenue [Line Items]
Total revenue	$ 11,860	$ 5,314	$ 30,646	$ 13,757
License—self-managed \| Revenue from Contract with Customer, Product and Service Benchmark \| Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	11%	8%	10%	8%
Professional services and other
Disaggregation of Revenue [Line Items]
Total revenue	$ 2,686	$ 1,712	$ 6,489	$ 4,558
Professional services and other \| Revenue from Contract with Customer, Product and Service Benchmark \| Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	2%	3%	2%	2%

Revenues - Disaggregation of _2

Revenues - Disaggregation of Revenue by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Disaggregation of Revenue [Line Items]
Total revenue	$ 112,981	$ 66,800	$ 301,429	$ 174,857
United States
Disaggregation of Revenue [Line Items]
Total revenue	94,942	56,706	251,339	147,226
Europe
Disaggregation of Revenue [Line Items]
Total revenue	15,547	9,165	43,285	24,631
Asia Pacific
Disaggregation of Revenue [Line Items]
Total revenue	$ 2,492	$ 929	$ 6,805	$ 3,000

Revenues - Narrative (Details)

Revenues - Narrative (Details) - USD ($) $ in Millions	3 Months Ended			9 Months Ended
Revenues - Narrative (Details) - USD ($) $ in Millions	Oct. 31, 2022	Apr. 30, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Jan. 31, 2022
Disaggregation of Revenue [Line Items]
Deferred revenue recognized	$ 77		$ 45	$ 141.9	$ 78.4
Remaining performance obligation	$ 392.7			$ 392.7		$ 312.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-11-01
Disaggregation of Revenue [Line Items]
Remaining performance obligation, percentage	71%			71%
Period of expected satisfaction (in months)	12 months			12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-11-01
Disaggregation of Revenue [Line Items]
Remaining performance obligation, percentage	92%			92%
Period of expected satisfaction (in months)	24 months			24 months
Accounts Receivable \| Credit Concentration Risk \| Three Distribution Channels - Entity One
Disaggregation of Revenue [Line Items]
Concentration risk, percentage				16%
Accounts Receivable \| Credit Concentration Risk \| Three Distribution Channels - Entity Two
Disaggregation of Revenue [Line Items]
Concentration risk, percentage				11%
Accounts Receivable \| Credit Concentration Risk \| Three Distribution Channels - Entity Three
Disaggregation of Revenue [Line Items]
Concentration risk, percentage				10%
Accounts Receivable \| Credit Concentration Risk \| One Distribution Channel
Disaggregation of Revenue [Line Items]
Concentration risk, percentage		14%
United States \| Revenue from Contract with Customer Benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	84%		85%	83%	84%

Cash, Cash Equivalents and Sh_3

Cash, Cash Equivalents and Short-Term Investments - Schedule of Cash and Short Term Investments (Details) $ in Thousands	Oct. 31, 2022 USD ($)
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 562,622
Gross Unrealized Gains	0
Gross Unrealized Losses	(7,039)
Fair Value	555,583
Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	372,174
Gross Unrealized Gains	0
Gross Unrealized Losses	(5)
Fair Value	372,169
Cash \| Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	279,997
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Fair Value	279,997
Money market funds \| Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	71,218
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Fair Value	71,218
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	39,112
Gross Unrealized Gains	0
Gross Unrealized Losses	(226)
Fair Value	38,886
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	49,338
Gross Unrealized Gains	0
Gross Unrealized Losses	(852)
Fair Value	48,486
Municipal bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	1,981
Gross Unrealized Gains	0
Gross Unrealized Losses	(30)
Fair Value	1,951
Foreign government bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	2,198
Gross Unrealized Gains	0
Gross Unrealized Losses	(42)
Fair Value	2,156
U.S. Agency securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	36,256
Gross Unrealized Gains	0
Gross Unrealized Losses	(492)
Fair Value	35,764
U.S. Agency securities \| Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	5,981
Gross Unrealized Gains	0
Gross Unrealized Losses	(4)
Fair Value	5,977
U.S. Treasury securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	433,737
Gross Unrealized Gains	0
Gross Unrealized Losses	(5,397)
Fair Value	428,340
U.S. Treasury securities \| Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	14,978
Gross Unrealized Gains	0
Gross Unrealized Losses	(1)
Fair Value	$ 14,977

Cash, Cash Equivalents and Sh_4

Cash, Cash Equivalents and Short-Term Investments - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Jan. 31, 2022
Cash and Cash Equivalents [Line Items]
Cash					$ 884,700
Interest and investment income	$ 4,700	$ 100	$ 8,200	$ 200
Net amortization of premiums or discounts on short-term investments	$ 2,100	$ 0	$ 3,346	$ 0
Certificates of Deposit
Cash and Cash Equivalents [Line Items]
Short-term investments					$ 50,000

Cash, Cash Equivalents and Sh_5

Cash, Cash Equivalents and Short-Term Investments - Schedule of Unrealized Losses Cash Equivalents and Short Term Investment (Details) $ in Thousands	Oct. 31, 2022 USD ($)
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Carrying Value	$ 566,538
Gross Unrealized Losses	(7,044)
Municipal bonds
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Carrying Value	1,951
Gross Unrealized Losses	(30)
Foreign government bonds
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Carrying Value	2,156
Gross Unrealized Losses	(42)
Commercial paper
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Carrying Value	33,886
Gross Unrealized Losses	(226)
U.S. Agency securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Carrying Value	41,741
Gross Unrealized Losses	(496)
Corporate debt securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Carrying Value	48,486
Gross Unrealized Losses	(852)
U.S. Treasury securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Carrying Value	438,318
Gross Unrealized Losses	$ (5,398)

Cash, Cash Equivalents and Sh_6

Cash, Cash Equivalents and Short-Term Investments - Schedule of Short Term Investments by Contractual Maturity (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Amortized cost
Due within 1 year	$ 433,053	$ 50,031
Due between 1 year to 2 years	129,569	0
Total	562,622	50,031
Fair Value
Due within 1 year	428,649	50,031
Due between 1 year to 2 years	126,934	0
Total	$ 555,583	$ 50,031

Fair Value Measurements (Detail

Fair Value Measurements (Details) $ in Thousands	Oct. 31, 2022 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	$ 555,583
Cash held in bank accounts	562,622
Contingent cash consideration	7,900
Cash and Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	372,169
Cash held in bank accounts	372,174
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent cash consideration	5,100
Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure	647,755
Fair Value, Recurring \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure	71,218
Fair Value, Recurring \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure	576,537
Fair Value, Recurring \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure	0
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	38,886
Cash held in bank accounts	39,112
Commercial paper \| Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	38,886
Commercial paper \| Fair Value, Recurring \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Commercial paper \| Fair Value, Recurring \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	38,886
Commercial paper \| Fair Value, Recurring \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	48,486
Cash held in bank accounts	49,338
Corporate debt securities \| Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	48,486
Corporate debt securities \| Fair Value, Recurring \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Corporate debt securities \| Fair Value, Recurring \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	48,486
Corporate debt securities \| Fair Value, Recurring \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Municipal bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	1,951
Cash held in bank accounts	1,981
Municipal bonds \| Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	1,951
Municipal bonds \| Fair Value, Recurring \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Municipal bonds \| Fair Value, Recurring \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	1,951
Municipal bonds \| Fair Value, Recurring \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Foreign government bonds \| Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	2,156
Foreign government bonds \| Fair Value, Recurring \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Foreign government bonds \| Fair Value, Recurring \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	2,156
Foreign government bonds \| Fair Value, Recurring \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
U.S. Agency securities \| Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	35,764
U.S. Agency securities \| Fair Value, Recurring \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
U.S. Agency securities \| Fair Value, Recurring \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	35,764
U.S. Agency securities \| Fair Value, Recurring \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	428,340
Cash held in bank accounts	433,737
U.S. Treasury securities \| Cash and Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	14,977
Cash held in bank accounts	14,978
U.S. Treasury securities \| Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	428,340
U.S. Treasury securities \| Fair Value, Recurring \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
U.S. Treasury securities \| Fair Value, Recurring \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	428,340
U.S. Treasury securities \| Fair Value, Recurring \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Cash \| Cash and Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	279,997
Cash held in bank accounts	279,997
Money market funds \| Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	71,218
Money market funds \| Fair Value, Recurring \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	71,218
Money market funds \| Fair Value, Recurring \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0
Money market funds \| Fair Value, Recurring \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0
U.S. Agency securities \| Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	5,977
U.S. Agency securities \| Fair Value, Recurring \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0
U.S. Agency securities \| Fair Value, Recurring \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	5,977
U.S. Agency securities \| Fair Value, Recurring \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0
U.S. Treasury securities \| Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	14,977
U.S. Treasury securities \| Fair Value, Recurring \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0
U.S. Treasury securities \| Fair Value, Recurring \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	14,977
U.S. Treasury securities \| Fair Value, Recurring \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 0

Supplemental Financial Statem_3

Supplemental Financial Statement Information - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands		Oct. 31, 2022	Jan. 31, 2022	Oct. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid software subscriptions		$ 7,028	$ 3,950
Prepaid advertising costs		737	722
Security and other deposits		1,005	981
Prepaid insurance		76	4,309
Prepaid income taxes		3,893	3,168
Restricted cash		2,500	0	$ 0
Interest receivable		1,485	49
Prepaid expenses for the Company’s events		1,093	266
Other prepaid expenses		1,818	1,834
Other current assets		819	265
Total prepaid expense and other current assets	[1]	$ 20,454	$ 15,544

[1](1) As of October 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $59.5 million and $17.7 million, respectively, and liabilities of $4.5 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Supplemental Financial Statem_4

Supplemental Financial Statement Information - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Jan. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, gross		$ 8,283		$ 8,283		$ 3,814
Less: Accumulated depreciation		(2,723)		(2,723)		(543)
Property and equipment, net	[1]	5,560		5,560		3,271
Depreciation		900	$ 0	2,200	$ 0
Computer and office equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross		7,315		7,315		3,049
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross		709		709		765
Others
Property, Plant and Equipment [Line Items]
Property and equipment, gross		$ 259		$ 259		$ 0

[1](1) As of October 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $59.5 million and $17.7 million, respectively, and liabilities of $4.5 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Supplemental Financial Statem_5

Supplemental Financial Statement Information - Schedule of Other Long-Term Assets (Details) - USD ($) $ in Thousands		Oct. 31, 2022	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Security and other deposits		$ 2,956	$ 2,832
Restricted cash		0	2,500
Deferred software implementation costs		1,088	969
Other long-term assets		759	850
Other long-term assets	[1]	$ 4,803	$ 7,151

[1](1) As of October 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $59.5 million and $17.7 million, respectively, and liabilities of $4.5 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Supplemental Financial Statem_6

Supplemental Financial Statement Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands		Oct. 31, 2022	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued expenses		$ 10,956	$ 8,605
Income taxes payable		1,646	319
ESPP employee contributions		4,406	6,557
Indirect taxes payable		1,725	4,044
Acquisition related contingent cash consideration		0	3,029
Acquisition related consideration withheld in escrow		2,500	0
Customer refunds		2,467	2,017
Other current liabilities		53	0
Accrued expenses and other current liabilities	[1]	$ 23,753	$ 24,571

[1](1) As of October 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $59.5 million and $17.7 million, respectively, and liabilities of $4.5 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Supplemental Financial Statem_7

Supplemental Financial Statement Information - Schedule of Accrued Compensation and Benefits (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued commissions	$ 6,841	$ 8,417
Payroll taxes payable	2,073	14,506
Other accrued team member related payables	7,802	9,897
Total accrued compensation and benefits	$ 16,716	$ 32,820

Supplemental Financial Statem_8

Supplemental Financial Statement Information - Other Long-Term Liabilities (Details) - USD ($) $ in Thousands		Oct. 31, 2022	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Early exercised options liability		$ 2,581	$ 6,837
Acquisition related contingent cash consideration		5,105	4,929
Acquisition related consideration withheld in escrow		0	2,500
Deferred tax liabilities		1,028	379
Contingent liability for labor matters		2,493	2,573
Long term taxes payable		737	784
Other long-term liabilities		181	0
Total other long-term liabilities	[1]	$ 12,125	$ 18,002

[1](1) As of October 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $59.5 million and $17.7 million, respectively, and liabilities of $4.5 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Supplemental Financial Statem_9

Supplemental Financial Statement Information - Other Income (Expense), Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Other Income and Expenses [Abstract]
Gain from deconsolidation of Meltano Inc.	$ 0	$ 0	$ 17,798	$ 0
Foreign exchange gains (losses), net	2,855	(9,831)	5,361	(19,703)
Other expense, net	(194)	(378)	(550)	(1,549)
Total other income (expense), net	$ 2,661	$ (10,209)	$ 22,609	$ (21,252)

Business Combination - Schedule

Business Combination - Schedule of Total Consideration Transferred (Details) - USD ($) $ in Thousands	Dec. 03, 2021	Oct. 31, 2022	Jan. 31, 2022
Business Acquisition [Line Items]
Contingent cash consideration (paid as of October 31, 2022)		$ 0	$ 3,029
Opstrace Inc.
Business Acquisition [Line Items]
Cash consideration	$ 2,970
Fair value of common stock issued on closing	959
Contingent common stock consideration (classified under additional paid-in capital)	1,754
Contingent cash consideration (paid as of October 31, 2022)	3,007
Contingent cash consideration (classified under other long-term liabilities as of October 31, 2022)	4,893
Consideration transferred	$ 13,583

Business Combination - Narrativ

Business Combination - Narrative (Details) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended		9 Months Ended
	Dec. 03, 2021	Sep. 30, 2022	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Business Acquisition [Line Items]
Contingent cash consideration			$ 7,900		$ 7,900
Partial settlement of acquisition related contingent cash consideration					3,137	$ 0
Accretion expense			100		300
General and administrative			33,186	$ 16,939	88,182	$ 40,276
Opstrace Inc.
Business Acquisition [Line Items]
Cash consideration held back	$ 2,500
Post-closing indemnification term	18 months
Partial settlement of acquisition related contingent cash consideration		$ 4,200
General and administrative			$ 1,100		$ 1,100

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, Net - Rollforward of Goodwill (Details) - USD ($) $ in Thousands		Oct. 31, 2022	Jan. 31, 2022
Goodwill [Roll Forward]
Goodwill	[1]	$ 8,145	$ 8,145

[1](1) As of October 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $59.5 million and $17.7 million, respectively, and liabilities of $4.5 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, Net - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended	9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Jul. 31, 2022	Oct. 31, 2022	Oct. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill impairment			$ 0	$ 0
Amortization of intangible assets	$ 600	$ 100		$ 1,767	$ 251

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets, Net - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Oct. 31, 2022	Jan. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 7,449	$ 7,602
Accumulated Amortization	(2,965)	(1,317)
Net Book Value	4,484	6,285
Developed technology from business combination
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	6,200	6,200
Accumulated Amortization	(1,880)	(334)
Net Book Value	$ 4,320	$ 5,866
Weighted average remaining amortization period (years)	2 years 1 month 6 days	2 years 9 months 18 days
Developed technology from asset acquisition
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 1,249	$ 1,402
Accumulated Amortization	(1,085)	(983)
Net Book Value	$ 164	$ 419
Weighted average remaining amortization period (years)	6 months	1 year 3 months 18 days

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets, Net - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
2023	$ 591
2024	2,166
2025	1,727
Total future amortization	$ 4,484	$ 6,285

Team Member Benefit Plans (Deta

Team Member Benefit Plans (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
Team Member Benefit Plans (Details) - USD ($) $ in Millions	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Retirement Benefits [Abstract]
Defined contribution plan, contribution amount	$ 0.7	$ 0.5	$ 2.8	$ 2

Equity - Narrative (Details)

Equity - Narrative (Details) $ / shares in Units, $ in Thousands	1 Months Ended				3 Months Ended			6 Months Ended	9 Months Ended		12 Months Ended
	Jun. 30, 2022 shares	May 31, 2022 USD ($)	Sep. 30, 2021 date shares	May 31, 2021 USD ($) shares	Oct. 31, 2022 USD ($) vote $ / shares shares	Oct. 31, 2021 USD ($)	Apr. 30, 2021	Jul. 31, 2021	Oct. 31, 2022 USD ($) vote $ / shares shares	Oct. 31, 2021 USD ($) $ / shares	Jan. 31, 2022 USD ($) $ / shares shares	Jan. 31, 2017	Oct. 18, 2021 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized (in shares) \| shares					50,000,000				50,000,000		50,000,000		50,000,000
Preferred stock, par value (in USD per share) \| $ / shares					$ 0.0000025				$ 0.0000025		$ 0.0000025		$ 0.0000025
Shares subject to repurchase obligation (in shares) \| shares					267,804				267,804		713,967
Deferred compensation liability, noncurrent					$ 2,600				$ 2,600		$ 6,800
Options granted (in shares) \| shares					0				0		7,936,000
Options granted (in USD per share) \| $ / shares										$ 12.74
Intrinsic value of options exercised					$ 26,600	$ 108,600
Weighted average grant date fair value (in dollars per share) \| $ / shares										$ 10.81
Aggregate intrinsic value, options vested									$ 86,500	$ 269,900
Compensation expense not yet recognized					53,600				53,600		$ 80,300
Stock-based compensation					33,708	8,579			88,926	17,242
Grant date fair value of RSUs granted				$ 8,800
Number of purchase dates \| date			4
Issuance of common stock under employee stock purchase plan									9,554
Tax benefit for stock-based compensation expense					$ 2,600	0			$ 5,800	0
Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares) \| shares					1,500,000,000				1,500,000,000		1,500,000,000		1,500,000,000
Common stock, par value (in USD per share) \| $ / shares					$ 0.0000025				$ 0.0000025		$ 0.0000025		$ 0.0000025
Voting rights, vote per share \| vote					1				1
Class B Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares) \| shares					250,000,000				250,000,000		250,000,000		250,000,000
Common stock, par value (in USD per share) \| $ / shares					$ 0.0000025				$ 0.0000025		$ 0.0000025		$ 0.0000025
Voting rights, vote per share \| vote					10				10
RSUs granted in period (in shares) \| shares				3,000,000
2021 Equity Incentive Plan \| Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for future issuance (in shares) \| shares			13,032,289
Shares subject to the 2021 ESPP \| 2021 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period for recognition (in years)									1 year 7 months 6 days
Stock-based compensation					$ 5,300				$ 19,400
Compensation expense not yet recognized					24,900				24,900
Discount rate (as a percent)			15%
Look-back period (in months)			27 months
Issuance of common stock under employee stock purchase plan		$ 300
Tax benefit for stock-based compensation expense					1,000				1,700
Plan modification, cost not yet recognized					7,700				$ 7,700
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period for recognition (in years)							2 years 8 months 12 days		2 years 3 months 18 days
Stock options \| 2015 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period (in years)												10 years
Stock options \| 2015 Equity Incentive Plan \| Period one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage												25%
Award vesting period (in years)												1 year
Stock options \| 2015 Equity Incentive Plan \| Period two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)												36 months
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense not yet recognized					237,000				$ 237,000		$ 21,500
Period for recognition (in years)								3 years 10 months 24 days	3 years 3 months 18 days
RSUs granted in period (in shares) \| shares									5,613,000		3,290,000
RSUs \| Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation					400	$ 800			$ 1,200	$ 800
Compensation expense not yet recognized					6,400				$ 6,400
RSUs \| Chief Executive Officer \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period for recognition (in years)									2 years
RSUs \| Chief Executive Officer \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period for recognition (in years)									7 years
RSUs \| 2021 Equity Incentive Plan \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)									2 years
RSUs \| 2021 Equity Incentive Plan \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)									4 years
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	100%
Period for recognition (in years)									3 years 1 month 6 days
RSUs granted in period (in shares) \| shares	400,000
Stock-based compensation					1,300				$ 2,000
Compensation expense not yet recognized					$ 18,000				$ 18,000
PSUs \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	0%
PSUs \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage	200%

Equity - Schedule of Stock Rese

Equity - Schedule of Stock Reserved For Future Issuance (Details) - shares	Oct. 31, 2022	Jan. 31, 2022	Jan. 31, 2021
Class of Stock [Line Items]
Options issued and outstanding (in shares)	13,873,000	17,146,000
Shares available for issuance under Equity Incentive Plans (in shares)	22,068,000	18,248,000	4,796,000
Class A and Class B common stock
Class of Stock [Line Items]
Options issued and outstanding (in shares)		17,146,000
Shares reserved for issuance to charitable organizations (in shares)	1,636,000	1,636,000
Common stock reserved for future issuance (in shares)	49,937,000	43,581,000
Unvested RSUs and PSUs \| Class A and Class B common stock
Class of Stock [Line Items]
Share-based compensation awards other than options (in shares)	7,909,000	3,280,000
Shares subject to the 2021 ESPP \| Class A and Class B common stock
Class of Stock [Line Items]
Share-based compensation awards other than options (in shares)	4,451,000	3,271,000

Equity - Awards Available for G

Equity - Awards Available for Grant (Details) - shares	3 Months Ended	9 Months Ended	12 Months Ended
Equity - Awards Available for Grant (Details) - shares	Oct. 31, 2022	Oct. 31, 2022	Jan. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Awards Available For Grant [Roll Forward]
Balance, beginning of period (in shares)		18,248,000	4,796,000
Awards authorized (in shares)		7,673,000	22,532,000
Options granted (in shares)	0	0	(7,936,000)
Options cancelled and forfeited (in shares)		1,280,000	2,044,000
Options repurchased (in shares)		62,000	92,000
Balance, end of period (in shares)	22,068,000	22,068,000	18,248,000
RSUs
Share-based Compensation Arrangement by Share-based Payment Award, Awards Available For Grant [Roll Forward]
RSUs granted (in shares)		(5,613,000)	(3,290,000)
RSUs cancelled and forfeited (in shares)		418,000	10,000

Equity - Summary of Stock Optio

Equity - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended	6 Months Ended	9 Months Ended	12 Months Ended
	Oct. 31, 2022	Jul. 31, 2022	Oct. 31, 2022	Jan. 31, 2022
Number of Stock Options Outstanding (in thousands)
Balance, beginning of period (in shares)		17,146,000	17,146,000
Options granted (in shares)	0		0	7,936,000
Options exercised (in shares)			(1,993,000)
Options cancelled (in shares)			(28,000)
Options forfeited (in shares)			(1,252,000)
Balance, end of period (in shares)	13,873,000		13,873,000	17,146,000
Options vested (in shares)	7,109,000		7,109,000
Options expected to vest (in shares)	13,873,000		13,873,000
Weighted Average Exercise Price
Balance, beginning of period (in USD per share)		$ 11.83	$ 11.83
Options granted (in USD per share)			0
Options exercised (in USD per share)			8.99
Options cancelled (in USD per share)			8.78
Options forfeited (in USD per share)			13.87
Balance, end of period (in USD per share)	$ 12.05		12.05	$ 11.83
Options vested (in USD per share)			8.80
Options expected to vest (in USD per share)			$ 12.05
Weighted Average Remaining Years
Beginning balance (in years)		8 years 2 months 26 days	7 years 2 months 1 day
Options granted (in years)
Options exercised (in years)
Options vested (in years)			6 years 5 months 1 day
Options expected to vest (in years)			7 years 2 months 1 day
Aggregate Intrinsic value (in millions)
Beginning balance		$ 894.8	$ 894.8
Ending balance	$ 505.1		505.1	$ 894.8
Options vested	281.9		281.9
Options expected to vest	$ 505.1		$ 505.1

Equity - Schedule of Restricted

Equity - Schedule of Restricted Stock Units Activity (Details) - RSUs	9 Months Ended
	Oct. 31, 2022 $ / shares shares
Number of Shares
Balance, beginning of period (in shares)	272,000
Granted (in shares)	5,248,000
Vested (in shares)	(558,000)
Canceled/forfeited (in shares)	(371,000)
Balance, ending of period (in shares)	4,591,000
Weighted- Average grant date fair value
Balance, beginning of period (in USD per share) \| $ / shares	$ 82.11
Granted (in USD per share) \| $ / shares	53.15
Vested (in USD per share) \| $ / shares	56.66
Canceled/forfeited (in USD per share) \| $ / shares	56.28
Balance, ending of period (in USD per share) \| $ / shares	$ 54.10
Chief Executive Officer
Number of Shares
Granted (in shares)	3,000,000

Equity - Schedule of Weighted A

Equity - Schedule of Weighted Average Fair Value Assumptions (Details) - Shares subject to the 2021 ESPP	9 Months Ended
	Oct. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield (as a percent)	0%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate (as a percent)	1.62%
Volatility (as a percent)	44.95%
Expected term (in years)	6 months
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate (as a percent)	2.63%
Volatility (as a percent)	52.76%
Expected term (in years)	2 years

Equity - Stock-Based Compensati

Equity - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense (1)	$ 33,708	$ 8,579	$ 88,926	$ 17,242
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense (1)	1,248	331	3,623	722
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense (1)	10,030	2,147	26,405	4,653
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense (1)	12,905	2,562	34,807	5,688
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense (1)	$ 9,525	$ 3,539	$ 24,091	$ 6,179

Joint Venture and Equity Meth_3

Joint Venture and Equity Method Investment - Narrative (Details) $ in Thousands, shares in Millions							1 Months Ended		3 Months Ended		9 Months Ended
		Sep. 07, 2022 USD ($)	Jul. 01, 2022 USD ($)	Apr. 04, 2022 USD ($)	Mar. 29, 2022 USD ($)	Jul. 31, 2018 USD ($)	Apr. 30, 2021 USD ($)	Feb. 28, 2021 USD ($) day	Oct. 31, 2022 USD ($)	Oct. 31, 2021 USD ($)	Oct. 31, 2022 USD ($) shares	Oct. 31, 2021 USD ($)	Jan. 31, 2022 USD ($)
Noncontrolling Interest [Line Items]
Stock-based compensation expense									$ 33,708	$ 8,579	$ 88,926	$ 17,242
Contributions received from noncontrolling interests, net of issuance costs											61,726	26,450
Decrease in net assets upon consolidation				$ 9,400
Decrease from deconsolidation											11,342
Gain from deconsolidation of Meltano Inc.									0	0	17,798	0
Carrying value of investment	[1]								13,624		13,624		$ 0
Loss from equity method investment, net of tax									(756)	$ 0	(1,775)	$ 0
Meltano Inc.
Noncontrolling Interest [Line Items]
Gain from deconsolidation of Meltano Inc.											17,800
Carrying value of investment									13,600		13,600
Loss from equity method investment, net of tax									(800)		$ (1,800)
Stake in equity method investment (as a percent)											97%
Noncontrolling Interests
Noncontrolling Interest [Line Items]
Stock-based compensation expense									2,500		$ 5,472
Decrease from deconsolidation											11,342
Noncontrolling Interests \| Meltano Inc.
Noncontrolling Interest [Line Items]
Decrease from deconsolidation				11,300
Accumulated Deficit \| Meltano Inc.
Noncontrolling Interest [Line Items]
Decrease from deconsolidation				15,900
JiHu
Noncontrolling Interest [Line Items]
Consideration received on transaction, net		$ 4,100	$ 22,800		$ 27,700
Stock-based compensation expense									2,500		5,500
Compensation expense not yet recognized									$ 15,800		$ 15,800
Period for recognition (in years)											3 years 6 months
Meltano Inc.
Noncontrolling Interest [Line Items]
Consideration received on transaction, net				$ 7,200
Contributions received from noncontrolling interests, net of issuance costs							$ 4,200
Meltano Inc. \| Employee stock options
Noncontrolling Interest [Line Items]
Potentially dilutive equity instruments (in shares) \| shares											2.9
Meltano Inc. \| Preferred Stock
Noncontrolling Interest [Line Items]
Stake in equity method investment (as a percent)											49%
Potentially dilutive equity instruments (in shares) \| shares											3.1
JiHu
Noncontrolling Interest [Line Items]
Ownership percentage by noncontrolling owners		72%
Ownership percentage		55%
Meltano Inc.
Noncontrolling Interest [Line Items]
Ownership percentage by noncontrolling owners							12%
Investment in subsidiary						$ 400
Variable Interest Entity, Primary Beneficiary \| JiHu
Noncontrolling Interest [Line Items]
Loans payable								$ 2,900
Loan payable, period (in days) \| day								10

[1](1) As of October 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $59.5 million and $17.7 million, respectively, and liabilities of $4.5 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Joint Venture and Equity Meth_4

Joint Venture and Equity Method Investment - Schedule of Inter-Company Eliminations (Details) - USD ($) $ in Thousands		3 Months Ended			9 Months Ended
		Oct. 31, 2022		Oct. 31, 2021	Oct. 31, 2022		Oct. 31, 2021	Jan. 31, 2022
Noncontrolling Interest [Line Items]
Revenue		$ 112,981		$ 66,800	$ 301,429		$ 174,857
Cost of revenue		14,564		7,195	37,442		20,812
Gross profit		98,417		59,605	263,987		154,045
Sales and marketing		81,080		50,543	228,479		133,562
Research and development		41,113		24,664	112,463		68,607
General and administrative		33,186		16,939	88,182		40,276
Total operating expenses		155,379		92,146	429,124		242,445
Loss from operations		(56,962)		(32,541)	(165,137)		(88,400)
Interest income		4,657		127	8,247		226
Total other income (expense), net		2,661		(10,209)	22,609		(21,252)
Net loss		(50,465)		(41,748)	(138,575)		(110,796)
Net loss attributable to noncontrolling interest		(2,010)		(521)	(4,997)		(1,443)
Cash and cash equivalents		372,169	[1]	824,714	372,169	[1]	824,714	$ 884,672	[1]
Property and equipment, net	[1]	5,560			5,560			3,271
Total assets	[1]	1,120,241			1,120,241			1,091,438
Total liabilities	[1]	305,550			305,550			292,169
Variable Interest Entity, Primary Beneficiary
Noncontrolling Interest [Line Items]
Revenue		1,275		265	3,388		297
Cost of revenue		481		243	1,193		604
Gross profit		794		22	2,195		(307)
Sales and marketing		1,999		780	5,251		1,630
Research and development		1,898		499	4,735		1,376
General and administrative		3,070		621	7,363		1,984
Total operating expenses		6,967		1,900	17,349		4,990
Loss from operations		(6,173)		(1,878)	(15,154)		(5,297)
Interest income		193		0	403		0
Total other income (expense), net		1,452		7	2,464		8
Net loss before income taxes		(4,528)		(1,871)	(12,287)		(5,289)
Net loss		(4,528)		(1,871)	(12,287)		(5,289)
Net loss attributable to noncontrolling interest		(2,010)		$ (521)	(4,997)		$ (1,443)
Cash and cash equivalents		55,573			55,573			14,198
Property and equipment, net		964			964			769
Other assets		2,965			2,965			2,765
Total assets		59,502			59,502			17,732
Total liabilities		$ 4,527			$ 4,527			$ 3,663

[1](1) As of October 31, 2022 and January 31, 2022, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $59.5 million and $17.7 million, respectively, and liabilities of $4.5 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Jan. 31, 2022
Income Tax Disclosure [Abstract]
Provision for (benefit from) income taxes	$ 65	$ (875)	$ 2,519	$ 1,370
Loss before income taxes and loss from equity method investment	(49,644)	$ (42,623)	(134,281)	$ (109,426)
Unrecognized tax benefits	5,600		5,600
Unrecognized tax benefits that would effect tax rate	$ 800		800
Interest and penalties recognized			$ 200		$ 100

Net Loss per Share - Schedule o

Net Loss per Share - Schedule of Earning Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Earnings Per Share [Abstract]
Net loss attributable to GitLab, Basic	$ (48,455)	$ (41,227)	$ (133,578)	$ (109,353)
Net loss attributable to GitLab, Diluted	$ (48,455)	$ (41,227)	$ (133,578)	$ (109,353)
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic	148,883,000	67,018,000	147,812,000	57,789,000
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, diluted	148,883,000	67,018,000	147,812,000	57,789,000
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic (in USD per share)	$ (0.33)	$ (0.62)	$ (0.90)	$ (1.89)
Net loss per share attributable to GitLab Class A and Class B common stockholders, diluted (in USD per share)	$ (0.33)	$ (0.62)	$ (0.90)	$ (1.89)

Net Loss per Share - Schedule_2

Net Loss per Share - Schedule of Potentially Dilutive Securities (Details) - shares shares in Thousands	9 Months Ended	12 Months Ended
	Oct. 31, 2022	Jan. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	22,200	21,396
Shares subject to outstanding common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	13,873	17,146
Unvested RSUs in connection with business combination
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	15	16
Unvested early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	268	714
Unvested RSUs and PSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	7,909	3,264
Shares subject to the 2021 ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	135	256

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions	9 Months Ended
	Oct. 31, 2022	Jan. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Purchase obligation period	3 years
Purchase obligation	$ 7.4
Purchase subscription	2.3
Estimate of possible loss	$ 2.5	$ 2.6